data_2mfj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mfj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.901 0.382 . . . . 0.0 110.488 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.471 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 40' ' ' CYS . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' LEU . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.43 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.703 0.287 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.473 ' HE1' ' HB3' ' A' ' 40' ' ' CYS . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.456 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 47' ' ' PRO . 5.1 t . . . . . 0 N--CA 1.436 -1.151 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.536 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 46' ' ' ARG . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 44' ' ' GLY . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.679 ' O ' HG23 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.98 0.419 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.635 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 47' ' ' PRO . 3.3 t . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HG2' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 47' ' ' PRO . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.414 ' HE3' ' HB3' ' A' ' 40' ' ' CYS . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 29' ' ' SER . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.414 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.426 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.426 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.427 ' OG1' ' HB1' ' A' ' 10' ' ' ALA . 11.9 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.712 0.292 . . . . 0.0 110.249 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' HB1' ' OG1' ' A' ' 7' ' ' THR . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 120.718 0.294 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 m . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.13 0 CA-C-O 121.053 0.454 . . . . 0.0 111.362 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.484 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.442 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.476 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.476 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.491 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 40' ' ' CYS . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.485 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.538 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.538 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.474 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.587 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.406 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.401 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.587 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.585 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.496 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 121.143 0.497 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.404 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.484 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.484 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.496 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 47' ' ' PRO . 4.8 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 23' ' ' GLN . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HD2' HG21 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.423 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.721 ' O ' HG22 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.489 0.185 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.677 0.275 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.422 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.798 0.333 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.555 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 43' ' ' ARG . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.563 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.454 ' HE2' ' HB3' ' A' ' 40' ' ' CYS . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.478 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.454 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -76.19 96.71 3.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.0 0.429 . . . . 0.0 110.187 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.48 154.12 49.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -77.49 -31.77 53.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -138.51 147.54 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.142 0.496 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -107.93 -19.94 13.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.355 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 t -119.88 150.19 40.87 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.488 -179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.532 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.471 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.51 ' HE3' ' HB3' ' A' ' 40' ' ' CYS . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 17' ' ' LEU . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.573 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.532 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.604 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.604 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.43 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.401 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m -114.31 143.3 45.1 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 58.5 65.27 1.28 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.734 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.5 m -94.43 153.84 17.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.697 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.61 -54.14 38.14 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.767 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -113.25 100.28 8.45 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.43 -22.03 2.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.73 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.8 -113.94 3.74 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.918 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.79 -79.96 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.787 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -160.22 151.23 19.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.621 0.248 . . . . 0.0 110.58 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -147.0 77.72 10.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.4 -35.07 19.09 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.663 2.242 . . . . 0.0 112.113 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -90.89 -17.29 26.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 mp 59.36 87.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.533 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.93 -171.4 1.24 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.813 2.342 . . . . 0.0 112.4 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -84.23 176.2 8.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.646 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.43 -52.5 6.12 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.326 -179.407 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.368 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -108.52 97.45 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.07 0.462 . . . . 0.0 111.298 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.18 143.13 50.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.881 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.7 pt? -97.39 7.28 46.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.938 0.875 . . . . 0.0 109.303 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -150.09 162.75 39.8 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.045 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -102.52 -20.65 14.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 109.391 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -124.44 137.48 54.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.398 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.473 ' HE1' ' HB3' ' A' ' 40' ' ' CYS . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.419 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.452 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.432 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.433 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.456 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m -137.85 162.62 33.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 60.38 44.33 12.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 109.579 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 83.5 m -91.64 163.46 14.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.997 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.52 48.29 57.83 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.55 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -100.23 83.52 2.68 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.29 164.37 32.89 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.76 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.93 141.02 5.33 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.5 -61.38 3.2 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.94 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -154.26 168.11 27.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -84.1 137.66 40.05 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.986 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.46 -43.56 10.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.707 2.271 . . . . 0.0 111.881 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.84 10.56 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.995 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mp 62.11 80.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.557 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -96.43 26.02 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.182 2.588 . . . . 0.0 110.93 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -161.36 -177.76 6.21 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.373 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.31 168.2 28.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.8 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -94.64 9.43 38.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.17 161.56 41.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 ' H ' HD21 ' A' ' 4' ' ' LEU . 2.0 pt? -76.7 -42.72 40.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.402 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.482 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 3.7 m-20 -90.1 108.24 19.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.891 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -95.62 -21.13 18.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.686 0.755 . . . . 0.0 109.362 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 47' ' ' PRO . 5.1 t -124.22 151.92 43.54 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.152 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.57 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.536 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.536 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.42 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.465 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 46' ' ' ARG . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.444 ' H ' ' C ' ' A' ' 44' ' ' GLY . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.679 ' O ' HG23 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -123.61 148.56 46.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 53' ' ' ARG . 8.3 mmt180 63.02 51.81 2.74 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.342 0.591 . . . . 0.0 112.053 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.3 m -92.38 135.99 33.57 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.6 61.23 6.94 Favored Glycine 0 C--O 1.238 0.406 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.093 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.12 106.87 16.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.495 0.664 . . . . 0.0 111.165 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 122.82 0.62 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.69 104.81 1.53 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.973 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.4 82.85 1.15 Allowed Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.5 164.53 38.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.187 0.517 . . . . 0.0 111.143 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.44 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 23.3 p90 -137.54 69.08 53.48 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.174 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.29 -28.84 8.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.852 2.368 . . . . 0.0 112.324 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.96 -11.47 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.4 mt 68.6 123.41 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.44 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 74.8 Cg_exo -51.02 174.21 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.332 2.688 . . . . 0.0 112.848 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.5 m -161.12 89.23 0.77 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -85.33 169.74 13.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.674 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -102.04 34.61 2.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.038 0.447 . . . . 0.0 110.821 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.2 179.87 6.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -74.87 -34.13 62.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.471 ' CG ' ' HB1' ' A' ' 10' ' ' ALA . 33.9 t0 -130.89 134.4 46.74 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -99.08 -10.45 22.55 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.389 0.614 . . . . 0.0 109.446 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -122.97 172.4 8.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.534 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.635 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.471 ' HB1' ' CG ' ' A' ' 5' ' ' ASP . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.635 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m -133.62 160.15 38.37 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 5.0 mmp_? 60.84 44.19 11.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.068 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.07 156.41 16.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.554 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.73 -107.74 2.0 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.849 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.43 132.59 36.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.34 -87.19 0.8 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.042 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.17 -110.1 3.44 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.901 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.16 144.7 15.55 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.136 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.67 173.63 16.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 29.8 m95 -92.8 126.85 50.14 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.94 -48.27 12.93 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.438 2.092 . . . . 0.0 112.719 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -138.98 30.48 2.24 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.244 -0.285 . . . . 0.0 110.897 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.8 mt 53.52 92.25 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.49 143.74 22.04 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.109 1.873 . . . . 0.0 110.429 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.3 p -161.29 155.65 22.89 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.656 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -91.58 -14.46 30.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.586 0.708 . . . . 0.0 109.231 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.608 0 CA-C-O 118.832 -0.982 . . . . 0.0 110.69 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -92.26 97.67 11.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.793 0.33 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.05 134.68 18.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD21 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -82.21 -33.05 29.51 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.999 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.34 143.21 48.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.922 0.391 . . . . 0.0 110.458 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -101.94 -21.35 14.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 47' ' ' PRO . 3.3 t -123.25 144.2 49.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HG2' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.456 ' HE1' ' HB3' ' A' ' 47' ' ' PRO . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.514 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.516 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.457 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.451 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.512 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.615 ' O ' HG23 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m -132.88 159.35 40.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 1.7 mmp_? 57.32 42.52 24.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.543 0.687 . . . . 0.0 109.878 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 13.7 t -104.67 170.46 7.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.564 -175.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.21 132.46 48.42 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -134.49 98.24 4.02 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.243 0.544 . . . . 0.0 110.633 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.46 -131.81 27.08 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.06 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.27 137.52 2.59 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.86 61.38 0.52 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.988 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -78.14 115.05 17.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.912 0.863 . . . . 0.0 111.511 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -102.94 115.82 63.52 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.251 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.84 -63.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.62 -17.26 30.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.925 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.8 mp 64.27 98.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 120.956 0.408 . . . . 0.0 111.904 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.58 85.79 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.475 2.117 . . . . 0.0 110.934 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -83.46 38.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.241 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.43 144.98 23.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.704 0.288 . . . . 0.0 110.407 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.028 178.787 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.952 0.406 . . . . 0.0 110.763 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.14 174.66 9.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.415 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -78.63 -47.34 17.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.497 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -97.44 132.17 43.39 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 7' ' ' THR . 33.4 p90 -103.8 -26.68 12.62 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.442 HG21 ' CD2' ' A' ' 6' ' ' PHE . 4.5 p -122.51 145.97 47.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.718 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.414 ' HE3' ' HB3' ' A' ' 40' ' ' CYS . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.402 ' O ' ' HG2' ' A' ' 33' ' ' GLN . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 29' ' ' SER . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.414 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.426 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.426 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HD2' ' CE2' ' A' ' 6' ' ' PHE . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t -133.76 161.56 34.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 61.29 45.91 8.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 110.088 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 75.9 m -86.66 140.5 29.76 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.736 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.37 45.45 6.52 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.966 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 53.11 30.53 9.82 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.05 -49.01 0.3 Allowed Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 119.907 -1.14 . . . . 0.0 112.872 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.93 1.08 61.66 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.356 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.53 -112.02 4.33 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.39 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -83.83 168.89 15.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.686 0.243 . . . . 0.0 110.424 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.592 ' CD1' ' HD2' ' A' ' 65' ' ' PRO . 22.0 m-90 58.73 52.17 4.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.667 0.604 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 61' ' ' TRP . 10.9 Cg_exo -71.93 -19.18 27.22 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.401 2.067 . . . . 0.0 111.969 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.33 13.3 5.56 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 mt 51.62 68.84 2.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.719 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.592 ' HD2' ' CD1' ' A' ' 61' ' ' TRP . 53.1 Cg_exo -58.16 133.27 54.27 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.067 1.845 . . . . 0.0 110.495 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.3 t -86.43 17.44 3.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 170.28 22.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.713 -1.048 . . . . 0.0 111.032 177.509 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -135.55 24.02 3.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.407 0.622 . . . . 0.0 109.992 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.5 111.31 15.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.468 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -74.22 -26.83 60.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.52 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 13.3 t0 -151.08 148.29 28.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.413 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 7' ' ' THR . 9.6 p90 -97.89 -24.09 15.56 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.958 0.409 . . . . 0.0 110.148 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.459 HG21 ' CD2' ' A' ' 6' ' ' PHE . 11.9 p -123.75 170.59 10.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.46 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.504 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.477 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.504 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 153.96 48.11 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 58.68 54.74 5.13 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.671 0.607 . . . . 0.0 110.776 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 76.2 m -89.59 -163.74 1.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.57 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 71.68 0.7 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.104 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -90.73 157.67 17.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.61 -169.92 14.7 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.53 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.03 99.76 1.18 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.269 -0.491 . . . . 0.0 111.971 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.5 100.44 0.34 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.27 136.39 27.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -154.38 80.03 4.81 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.96 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.03 -43.3 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.681 2.254 . . . . 0.0 112.237 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -89.86 -26.22 20.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.474 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.9 mt 71.78 86.58 0.11 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.704 0.627 . . . . 0.0 109.749 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 2.91 6.86 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.946 2.43 . . . . 0.0 113.258 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -80.55 103.51 10.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.065 0.46 . . . . 0.0 109.826 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.7 1.25 53.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 CA-C-O 118.294 -1.281 . . . . 0.0 110.27 -176.171 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 58.3 45.45 17.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.124 0.487 . . . . 0.0 110.327 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.43 169.62 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.511 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -76.4 -21.46 55.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.825 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -137.45 150.41 47.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.989 0.424 . . . . 0.0 110.768 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -104.46 -25.86 12.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -123.94 146.01 48.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.374 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.552 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.442 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.466 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.411 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.6 m -122.51 150.39 42.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.5 mmp_? 59.63 54.15 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.402 0.62 . . . . 0.0 111.001 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.2 m -92.34 165.58 13.01 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.517 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.41 23.01 4.91 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -159.44 166.42 31.03 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.42 -57.21 0.44 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 60' ' ' GLU . . . 128.44 -13.01 6.26 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.325 177.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.34 -37.91 1.81 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.807 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 58' ' ' GLY . 36.4 mt-10 -163.36 -22.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.611 1.164 . . . . 0.0 110.27 -177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -74.73 120.6 82.35 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.15 96.72 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.829 2.353 . . . . 0.0 112.093 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 10.4 t30 76.99 1.73 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.342 175.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt 70.76 85.85 0.12 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.455 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -73.01 170.76 19.02 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.553 2.168 . . . . 0.0 110.334 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 m -85.31 159.79 19.96 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.458 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -81.39 -20.77 39.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.575 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.225 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 p -82.75 51.56 1.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.976 0.417 . . . . 0.0 111.383 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.44 147.6 38.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.51 -24.4 50.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.35 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.26 146.3 34.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.688 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -106.77 -15.63 14.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.412 0.625 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.481 HG22 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -114.72 144.46 43.42 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.362 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HB2' HG22 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.484 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.442 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.469 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.476 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.476 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.513 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m -136.89 161.6 35.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.533 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.1 mmp_? 62.99 39.87 9.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 61.2 m -89.48 -170.76 2.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 49.94 3.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.734 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -115.47 -4.49 12.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 110.582 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 -66.65 3.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.288 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.88 -169.83 32.49 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.245 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 70.33 1.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.398 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.49 145.73 34.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.081 0.467 . . . . 0.0 110.778 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -125.06 107.1 28.24 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.933 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.65 -34.85 49.88 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.21 1.94 . . . . 0.0 111.512 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.53 -19.85 22.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.38 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.4 mt 54.57 86.52 0.16 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 123.36 0.413 . . . . 0.0 111.479 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.94 68.39 5.72 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.511 2.14 . . . . 0.0 112.794 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -72.81 -35.54 67.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 110.526 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -93.64 133.26 37.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.225 177.147 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.35 -178.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -80.24 74.5 7.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.12 0.486 . . . . 0.0 110.222 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.55 139.6 20.11 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.442 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.425 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.0 pt? -83.39 -35.35 25.15 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.453 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.12 118.18 29.46 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.843 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' CD2' HG23 ' A' ' 7' ' ' THR . 11.4 p90 -99.91 -26.65 13.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.411 HG23 ' CD2' ' A' ' 6' ' ' PHE . 19.5 p -123.87 168.25 13.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.505 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.432 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.491 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.491 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.493 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.401 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -125.49 152.57 44.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? 61.22 49.13 5.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.281 0.562 . . . . 0.0 110.379 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.4 m -90.19 156.38 18.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.048 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.82 28.45 12.24 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -100.41 76.95 1.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.637 -0.781 . . . . 0.0 109.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.62 119.92 5.0 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.818 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.09 -68.13 0.24 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.258 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.32 134.67 10.84 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.434 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.25 143.63 17.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.239 0.543 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.73 89.8 2.88 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.793 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.83 -39.14 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.662 2.241 . . . . 0.0 113.52 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.11 -17.61 49.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.162 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.5 mt 66.79 93.74 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.824 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.87 -18.61 52.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.532 2.155 . . . . 0.0 111.788 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -160.55 149.9 17.29 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.845 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 146.89 31.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.708 0.289 . . . . 0.0 110.617 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.189 0 CA-C-O 118.991 -0.894 . . . . 0.0 111.146 178.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.66 37.63 4.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.337 0.589 . . . . 0.0 110.032 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.12 142.69 44.29 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.576 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 5' ' ' ASP . 2.2 pt? -77.81 -47.85 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.105 0.479 . . . . 0.0 110.004 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.464 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 20.9 m-20 -91.75 95.52 9.92 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' CD2' HG21 ' A' ' 7' ' ' THR . 11.7 p90 -95.48 -17.83 21.16 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.435 HG21 ' CD2' ' A' ' 6' ' ' PHE . 9.4 p -124.53 160.43 28.38 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.997 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.568 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.476 ' HE2' ' HB3' ' A' ' 40' ' ' CYS . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.523 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.568 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.485 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.476 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -137.59 162.56 33.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 53' ' ' ARG . 10.4 mmt180 64.67 42.92 4.47 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.429 0.456 . . . . 0.0 110.547 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.7 m -83.79 135.86 34.37 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.31 26.62 69.89 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -171.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -155.25 170.61 21.46 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.327 -0.937 . . . . 0.0 110.196 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.89 -176.13 46.71 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 -122.65 0.63 Allowed Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.79 -44.08 91.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.333 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.91 165.55 24.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.797 0.332 . . . . 0.0 110.372 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -79.12 126.07 82.46 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.767 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.36 87.51 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.759 2.306 . . . . 0.0 111.907 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t30 70.5 3.71 4.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.545 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mp 65.04 93.56 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 111.12 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.76 -171.57 1.0 Allowed 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.637 2.224 . . . . 0.0 112.284 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -82.13 130.02 34.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -91.22 -23.61 20.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.44 0.638 . . . . 0.0 109.749 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.144 0 CA-C-O 118.061 -1.411 . . . . 0.0 110.862 -179.46 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p 49.37 27.17 1.85 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.801 0.84 . . . . 0.0 112.832 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.3 162.72 15.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.588 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -74.95 -26.4 59.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.568 179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -141.91 151.71 42.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -99.54 -21.38 15.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -124.05 145.52 49.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.538 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.55 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.466 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HD2' HG21 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.538 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.528 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m -126.69 151.85 47.56 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.529 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.6 mmp_? 61.19 52.7 3.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.347 0.594 . . . . 0.0 111.246 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.2 m -90.75 158.05 17.08 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.507 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.58 -55.83 11.09 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.096 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 57.82 78.1 0.25 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.405 0.622 . . . . 0.0 110.542 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.68 60.14 0.25 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.68 84.05 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.232 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.7 171.36 38.11 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.031 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -84.62 -32.28 23.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.227 0.537 . . . . 0.0 109.888 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -127.48 93.19 41.3 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.53 -35.03 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.394 2.063 . . . . 0.0 112.659 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -90.51 -24.46 20.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt 70.27 86.93 0.11 Allowed Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.007 0.523 . . . . 0.0 111.525 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -88.93 65.21 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.896 2.397 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -157.54 157.37 33.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.122 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -84.56 -61.1 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 0.0 110.426 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.62 0 CA-C-O 118.054 -1.414 . . . . 0.0 110.722 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -102.68 93.86 5.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.014 0.435 . . . . 0.0 111.166 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.52 132.25 55.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.24 -42.98 35.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.42 149.35 37.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.834 0.349 . . . . 0.0 110.718 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 7' ' ' THR . 12.4 p90 -108.62 -31.38 7.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.464 HG22 ' CD2' ' A' ' 6' ' ' PHE . 11.6 p -122.24 152.34 40.12 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.381 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.658 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.474 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.587 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.406 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.406 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.444 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.658 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.401 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.498 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.587 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m -128.67 153.56 47.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 1.5 mmp_? 62.72 48.68 4.1 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.553 0.533 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.443 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.7 m -91.53 -179.13 5.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.979 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.74 109.94 3.15 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.862 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -153.2 148.56 27.03 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.95 104.8 2.25 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.9 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.219 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.52 -76.6 2.22 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.685 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.73 -175.55 5.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.456 ' HB3' ' HD3' ' A' ' 65' ' ' PRO . 82.3 m95 -136.89 130.19 17.53 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.9 -46.52 28.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.835 2.357 . . . . 0.0 113.277 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -137.27 24.52 2.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.446 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.4 mt 54.2 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.117 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 94.7 Cg_endo -78.55 60.45 7.59 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.722 2.281 . . . . 0.0 112.043 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -83.38 157.79 22.38 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.45 ' C ' ' HD3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -85.21 -41.81 15.28 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.629 178.237 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -96.74 92.66 6.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.5 140.18 14.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.822 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' H ' HD21 ' A' ' 4' ' ' LEU . 2.0 pt? -82.84 -44.81 15.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.782 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -98.01 123.4 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.743 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.65 -20.72 14.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.33 0.586 . . . . 0.0 110.256 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -123.4 158.59 30.79 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.307 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.482 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.585 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.496 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.49 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.496 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.422 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.544 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.632 ' CZ ' ' HA ' ' A' ' 53' ' ' ARG . 2.9 mmp_? 59.84 46.74 10.96 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.517 0.675 . . . . 0.0 110.56 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.8 m -92.97 163.32 13.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.261 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.03 35.02 4.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.474 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -96.7 -153.77 0.42 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.61 108.23 0.67 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.29 -142.17 17.4 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.934 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.56 36.04 1.8 Allowed Glycine 0 C--N 1.316 -0.573 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.99 -179.36 7.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.169 0.509 . . . . 0.0 111.401 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -99.22 106.44 38.71 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.94 -56.72 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.44 2.093 . . . . 0.0 112.994 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -83.54 -9.12 59.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.068 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.5 mt 62.6 80.1 0.25 Allowed Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.073 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.86 165.01 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.543 2.162 . . . . 0.0 113.015 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 t -86.1 -160.01 0.51 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.247 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.41 ' HD3' ' N ' ' A' ' 67' ' ' ARG . 1.3 mpp_? -94.43 -65.88 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 118.296 -1.28 . . . . 0.0 111.813 178.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.016 -0.433 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m 64.96 18.87 11.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.977 0.511 . . . . 0.0 111.177 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.23 164.37 38.43 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.18 0.514 . . . . 0.0 111.743 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -74.47 -21.73 59.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.293 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.11 151.41 43.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.757 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -111.76 -14.99 13.5 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.464 0.65 . . . . 0.0 109.885 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.1 131.63 54.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.284 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.478 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.412 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.404 ' O ' HG21 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.484 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.496 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.413 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.5 mmt180 60.65 47.78 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.541 0.686 . . . . 0.0 109.565 -175.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.6 m -101.55 136.77 40.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.244 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.84 -77.46 0.21 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -83.56 -168.02 1.94 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.04 58.54 13.14 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 118.239 -1.934 . . . . 0.0 108.78 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.6 163.37 36.93 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 114.613 -0.794 . . . . 0.0 111.301 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.33 3.38 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG3' ' HD3' ' A' ' 62' ' ' PRO . 5.7 tp10 -165.71 162.19 18.57 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.081 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.546 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 32.6 p90 -162.18 63.81 1.56 Allowed Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.134 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 91.9 Cg_endo -93.72 3.11 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.822 2.348 . . . . 0.0 112.263 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -146.42 9.91 1.09 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.57 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.7 mt 71.73 107.31 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.978 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 73.8 Cg_endo -85.64 51.07 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.018 2.479 . . . . 0.0 112.491 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -79.9 -5.38 55.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.283 0.563 . . . . 0.0 110.8 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -88.91 -174.96 4.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.734 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.145 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.329 177.943 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -83.67 69.63 10.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.069 0.461 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.79 147.56 26.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.751 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 4' ' ' LEU . 1.3 pt? -80.3 -31.82 38.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.39 145.92 50.77 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -106.54 -24.45 12.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.781 0.8 . . . . 0.0 108.888 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.721 HG22 ' O ' ' A' ' 47' ' ' PRO . 4.8 t -123.91 153.8 40.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.704 177.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.504 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 23' ' ' GLN . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.494 ' HD2' HG21 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.423 ' HB3' ' HE1' ' A' ' 12' ' ' MET . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.721 ' O ' HG22 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m -125.68 152.65 44.97 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 62.03 51.2 3.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.198 0.523 . . . . 0.0 109.962 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 51' ' ' CYS . 71.1 m -99.21 159.83 14.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.822 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.91 124.03 22.84 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -151.1 154.03 36.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 117.253 0.526 . . . . 0.0 110.826 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.47 -77.7 0.11 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.41 19.32 79.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.286 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.06 -146.28 21.91 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.968 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -156.52 153.6 29.0 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.447 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 6.2 m-90 -136.81 86.92 20.63 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.02 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.35 -59.62 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.324 2.016 . . . . 0.0 111.991 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.26 6.59 44.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.174 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.447 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 82.3 mt 57.84 71.39 1.07 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.14 99.88 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.636 2.224 . . . . 0.0 111.475 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -154.99 157.21 37.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -84.18 -30.95 25.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.169 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.426 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -80.78 91.88 5.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.723 0.296 . . . . 0.0 110.862 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.67 149.06 14.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -77.74 -27.01 50.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -125.66 149.46 48.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.71 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -102.94 -27.06 12.86 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -123.94 134.71 53.46 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.691 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.523 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.602 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.405 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.424 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.438 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.523 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m -130.94 152.98 49.67 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 59.07 52.27 6.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 70.8 m -86.84 -169.82 2.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.282 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.03 83.35 0.09 OUTLIER Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.649 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -86.71 25.79 1.21 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 122.894 0.478 . . . . 0.0 111.652 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.73 -98.06 0.51 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.481 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.92 36.49 0.53 Allowed Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.679 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.68 -143.72 16.68 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.408 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.68 -36.16 13.77 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.451 ' HB2' HD23 ' A' ' 64' ' ' LEU . 90.0 m95 -145.13 132.34 10.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.65 -39.42 83.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.246 2.631 . . . . 0.0 113.515 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.58 13.6 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.025 0.441 . . . . 0.0 111.107 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.451 HD23 ' HB2' ' A' ' 61' ' ' TRP . 61.1 mt 60.29 84.53 0.2 Allowed Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.357 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.42 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 98.3 Cg_endo -87.24 -1.47 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.472 2.115 . . . . 0.0 111.931 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -79.87 141.8 35.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.001 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 2.4 mmp_? -87.51 -17.54 31.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.796 0.331 . . . . 0.0 111.168 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.486 0 CA-C-O 118.809 -0.995 . . . . 0.0 111.756 -179.525 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -123.97 23.21 8.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.454 0.645 . . . . 0.0 109.992 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.36 108.38 19.98 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.664 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -81.34 -37.66 27.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.916 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -105.67 141.25 37.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -106.34 -29.4 9.78 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.023 0.44 . . . . 0.0 110.607 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -124.12 145.89 48.99 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.007 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.448 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.452 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.408 ' HB2' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.587 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.486 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.408 ' HB3' ' HE3' ' A' ' 12' ' ' MET . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.448 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -127.24 153.58 45.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 mmp_? 58.34 55.87 4.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 111.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.532 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.3 m -90.05 154.48 19.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 51.54 3.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.917 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -72.66 -43.71 62.8 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.963 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.29 100.44 2.44 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.867 -1.159 . . . . 0.0 111.87 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.6 -17.74 1.19 Allowed Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.93 67.6 1.81 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.9 131.75 35.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -136.89 86.15 21.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.616 0.246 . . . . 0.0 110.679 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.59 88.84 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.639 2.226 . . . . 0.0 111.04 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 35.59 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt 68.46 105.57 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.133 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.41 34.44 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.224 2.616 . . . . 0.0 113.682 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 m -149.63 147.58 28.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.35 . . . . 0.0 110.999 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.82 169.03 20.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.39 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.418 -1.212 . . . . 0.0 111.632 -179.776 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -80.19 96.55 6.6 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.369 0.604 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.03 149.49 24.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -79.04 -27.39 43.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.94 0.4 . . . . 0.0 110.333 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.43 147.82 33.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -102.31 -25.56 13.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.027 0.441 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -123.7 152.08 42.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.216 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.447 ' HG2' ' HB1' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.478 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.442 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.523 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' HB1' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.555 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.555 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.521 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.521 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.461 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 43' ' ' ARG . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.563 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m -134.74 156.69 48.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.42 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 22.1 mmt180 59.0 54.94 4.72 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 121.389 0.614 . . . . 0.0 111.323 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 81.0 m -91.48 149.5 21.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.513 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.92 -96.37 0.59 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.326 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -132.41 -53.58 0.95 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.59 -113.29 0.45 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.75 -50.94 0.54 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.602 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.59 74.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.815 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.74 174.04 15.64 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.73 0.3 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -144.99 87.22 7.33 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-O 121.471 0.653 . . . . 0.0 111.209 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.2 -24.05 8.39 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.804 2.336 . . . . 0.0 112.666 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.85 -21.72 31.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.3 mt 64.66 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.158 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.64 171.53 16.57 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.158 1.906 . . . . 0.0 110.747 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -76.66 96.55 4.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -83.06 129.03 34.99 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.544 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.093 0 CA-C-O 118.206 -1.33 . . . . 0.0 110.574 177.527 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m -90.59 19.13 5.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.455 0.645 . . . . 0.0 111.272 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.26 165.9 13.67 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.775 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.5 pt? -82.62 -47.91 11.54 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.845 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.417 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 1.6 m-20 -94.91 132.04 40.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.052 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.6 p90 -102.97 -27.79 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -122.25 154.26 37.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.805 175.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.616 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.454 ' HE2' ' HB3' ' A' ' 40' ' ' CYS . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.534 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.499 ' O ' HG22 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.616 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.465 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.478 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.454 ' HB3' ' HE2' ' A' ' 12' ' ' MET . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m -139.28 160.2 40.38 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.3 mmp_? 57.78 64.98 1.41 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.09 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' CYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.2 m -87.2 145.06 26.55 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.81 -82.63 0.27 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.741 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.24 175.86 10.52 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.442 0.639 . . . . 0.0 112.272 -173.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.91 145.62 12.38 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.04 61.77 1.4 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.501 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.74 42.3 1.39 Allowed Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -149.0 146.54 27.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -146.02 78.1 11.66 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 87.79 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.149 1.899 . . . . 0.0 111.477 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 t30 57.01 46.14 19.87 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 64' ' ' LEU . 2.9 pp 46.11 103.71 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.344 1.057 . . . . 0.0 113.223 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.82 158.31 55.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.194 1.929 . . . . 0.0 112.201 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.5 m -81.49 -1.59 46.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.38 0.609 . . . . 0.0 110.408 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -85.84 113.62 22.13 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.752 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.446 0 CA-C-O 118.331 -1.26 . . . . 0.0 111.695 -179.383 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 47' ' ' PRO . 2.7 t . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.901 0.382 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 11' ' ' ARG . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.703 0.287 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.468 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.685 HG21 ' O ' ' A' ' 47' ' ' PRO . 5.1 t . . . . . 0 N--CA 1.436 -1.151 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.476 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.685 ' O ' HG21 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.98 0.419 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.653 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 31' ' ' LYS . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 47' ' ' PRO . 3.3 t . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.453 ' CE ' ' HB3' ' A' ' 40' ' ' CYS . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' O ' HG21 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.453 HG22 ' HD2' ' A' ' 31' ' ' LYS . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.487 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.712 0.292 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 120.718 0.294 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.601 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 27' ' ' ILE . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 52' ' ' SER . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 m . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.13 0 CA-C-O 121.053 0.454 . . . . 0.0 111.362 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.439 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.535 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 43' ' ' ARG . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 41' ' ' GLU . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' HA2' HH21 ' A' ' 42' ' ' ARG . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 17' ' ' LEU . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD2' HG22 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HD2' HG22 ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.592 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 47' ' ' PRO . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.577 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 121.143 0.497 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.514 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.512 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' PRO . 4.8 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.543 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG22 ' HD2' ' A' ' 31' ' ' LYS . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' HG22 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.731 ' O ' HG21 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.489 0.185 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.677 0.275 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.462 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.491 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.798 0.333 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.578 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -76.19 96.71 3.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.0 0.429 . . . . 0.0 110.187 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.48 154.12 49.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.5 pt? -77.49 -31.77 53.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -138.51 147.54 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.142 0.496 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -107.93 -19.94 13.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.355 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 47' ' ' PRO . 2.7 t -119.88 150.19 40.87 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.488 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 11' ' ' ARG . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m -114.31 143.3 45.1 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 58.5 65.27 1.28 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.734 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.5 m -94.43 153.84 17.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.697 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.61 -54.14 38.14 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.767 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -113.25 100.28 8.45 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.43 -22.03 2.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.73 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.8 -113.94 3.74 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.918 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.79 -79.96 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.787 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -160.22 151.23 19.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.621 0.248 . . . . 0.0 110.58 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -147.0 77.72 10.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.4 -35.07 19.09 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.663 2.242 . . . . 0.0 112.113 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -90.89 -17.29 26.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 mp 59.36 87.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.533 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.93 -171.4 1.24 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.813 2.342 . . . . 0.0 112.4 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -84.23 176.2 8.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.652 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.43 -52.5 6.12 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.326 -179.407 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.368 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -108.52 97.45 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.07 0.462 . . . . 0.0 111.298 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.18 143.13 50.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.881 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.634 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.7 pt? -97.39 7.28 46.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.938 0.875 . . . . 0.0 109.303 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -150.09 162.75 39.8 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.045 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -102.52 -20.65 14.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 109.391 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -124.44 137.48 54.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.398 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.468 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m -137.85 162.62 33.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 60.38 44.33 12.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 109.579 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.5 m -91.64 163.46 14.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.997 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.52 48.29 57.83 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.55 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -100.23 83.52 2.68 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.29 164.37 32.89 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.76 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.93 141.02 5.33 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.5 -61.38 3.2 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.94 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -154.26 168.11 27.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -84.1 137.66 40.05 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.986 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.46 -43.56 10.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.707 2.271 . . . . 0.0 111.881 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.84 10.56 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.995 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mp 62.11 80.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.557 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -96.43 26.02 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.182 2.588 . . . . 0.0 110.93 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -161.36 -177.76 6.21 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.373 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.31 168.2 28.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.8 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -94.64 9.43 38.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.17 161.56 41.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.0 pt? -76.7 -42.72 40.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.402 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 3.7 m-20 -90.1 108.24 19.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.891 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -95.62 -21.13 18.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.686 0.755 . . . . 0.0 109.362 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.685 HG21 ' O ' ' A' ' 47' ' ' PRO . 5.1 t -124.22 151.92 43.54 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.152 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.476 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.685 ' O ' HG21 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -123.61 148.56 46.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 53' ' ' ARG . 8.3 mmt180 63.02 51.81 2.74 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.342 0.591 . . . . 0.0 112.053 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.3 m -92.38 135.99 33.57 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.6 61.23 6.94 Favored Glycine 0 C--O 1.238 0.406 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.093 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.12 106.87 16.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.495 0.664 . . . . 0.0 111.165 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 122.82 0.62 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.69 104.81 1.53 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.973 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.4 82.85 1.15 Allowed Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.5 164.53 38.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.187 0.517 . . . . 0.0 111.143 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 23.3 p90 -137.54 69.08 53.48 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.174 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.29 -28.84 8.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.852 2.368 . . . . 0.0 112.324 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -91.96 -11.47 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.4 mt 68.6 123.41 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 74.8 Cg_exo -51.02 174.21 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.332 2.688 . . . . 0.0 112.848 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.5 m -161.12 89.23 0.77 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -85.33 169.74 13.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.674 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.501 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -102.04 34.61 2.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.038 0.447 . . . . 0.0 110.821 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.2 179.87 6.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.7 pt? -74.87 -34.13 62.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.877 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 33.9 t0 -130.89 134.4 46.74 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -99.08 -10.45 22.55 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.389 0.614 . . . . 0.0 109.446 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -122.97 172.4 8.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.534 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.653 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' CG ' ' A' ' 5' ' ' ASP . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 31' ' ' LYS . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m -133.62 160.15 38.37 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 5.0 mmp_? 60.84 44.19 11.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.068 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.07 156.41 16.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.554 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.73 -107.74 2.0 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.849 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.43 132.59 36.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.34 -87.19 0.8 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.042 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.17 -110.1 3.44 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.901 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.16 144.7 15.55 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.136 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.67 173.63 16.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB2' HD23 ' A' ' 64' ' ' LEU . 29.8 m95 -92.8 126.85 50.14 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.94 -48.27 12.93 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.438 2.092 . . . . 0.0 112.719 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -138.98 30.48 2.24 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.244 -0.285 . . . . 0.0 110.897 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 61' ' ' TRP . 63.8 mt 53.52 92.25 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.49 143.74 22.04 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.109 1.873 . . . . 0.0 110.429 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.3 p -161.29 155.65 22.89 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.656 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -91.58 -14.46 30.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.586 0.708 . . . . 0.0 109.231 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.608 0 CA-C-O 118.832 -0.982 . . . . 0.0 110.69 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -92.26 97.67 11.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.793 0.33 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.05 134.68 18.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.595 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -82.21 -33.05 29.51 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.999 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.34 143.21 48.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.922 0.391 . . . . 0.0 110.458 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -101.94 -21.35 14.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 47' ' ' PRO . 3.3 t -123.25 144.2 49.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.453 ' CE ' ' HB3' ' A' ' 40' ' ' CYS . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' O ' HG21 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m -132.88 159.35 40.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 1.7 mmp_? 57.32 42.52 24.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.543 0.687 . . . . 0.0 109.878 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 13.7 t -104.67 170.46 7.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.564 -175.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.21 132.46 48.42 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -134.49 98.24 4.02 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.243 0.544 . . . . 0.0 110.633 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.46 -131.81 27.08 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.06 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.27 137.52 2.59 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.86 61.38 0.52 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.988 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.1 pm0 -78.14 115.05 17.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.912 0.863 . . . . 0.0 111.511 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 5.5 m-90 -102.94 115.82 63.52 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.251 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 61' ' ' TRP . 19.6 Cg_endo -63.84 -63.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.62 -17.26 30.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.925 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 6.8 mp 64.27 98.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 120.956 0.408 . . . . 0.0 111.904 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.58 85.79 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.475 2.117 . . . . 0.0 110.934 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -83.46 38.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.241 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.43 144.98 23.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.704 0.288 . . . . 0.0 110.407 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.028 178.787 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.952 0.406 . . . . 0.0 110.763 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.14 174.66 9.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.415 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.577 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -78.63 -47.34 17.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.497 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -97.44 132.17 43.39 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.452 ' CD2' HG23 ' A' ' 7' ' ' THR . 33.4 p90 -103.8 -26.68 12.62 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.452 HG23 ' CD2' ' A' ' 6' ' ' PHE . 4.5 p -122.51 145.97 47.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.718 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.453 HG22 ' HD2' ' A' ' 31' ' ' LYS . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.487 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 6' ' ' PHE . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t -133.76 161.56 34.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 61.29 45.91 8.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 110.088 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 75.9 m -86.66 140.5 29.76 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.736 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.37 45.45 6.52 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.966 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 53.11 30.53 9.82 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.05 -49.01 0.3 Allowed Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 119.907 -1.14 . . . . 0.0 112.872 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.93 1.08 61.66 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.356 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.53 -112.02 4.33 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.39 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -83.83 168.89 15.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.686 0.243 . . . . 0.0 110.424 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.604 ' CD1' ' HD2' ' A' ' 65' ' ' PRO . 22.0 m-90 58.73 52.17 4.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.667 0.604 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 61' ' ' TRP . 10.9 Cg_exo -71.93 -19.18 27.22 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.401 2.067 . . . . 0.0 111.969 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.33 13.3 5.56 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 mt 51.62 68.84 2.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.719 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' CD1' ' A' ' 61' ' ' TRP . 53.1 Cg_exo -58.16 133.27 54.27 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.067 1.845 . . . . 0.0 110.495 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.3 t -86.43 17.44 3.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 170.28 22.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.713 -1.048 . . . . 0.0 111.032 177.509 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -135.55 24.02 3.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.407 0.622 . . . . 0.0 109.992 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.5 111.31 15.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.468 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -74.22 -26.83 60.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 13.3 t0 -151.08 148.29 28.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.413 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CD2' HG23 ' A' ' 7' ' ' THR . 9.6 p90 -97.89 -24.09 15.56 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.958 0.409 . . . . 0.0 110.148 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 ' CD2' ' A' ' 6' ' ' PHE . 11.9 p -123.75 170.59 10.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 153.96 48.11 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 58.68 54.74 5.13 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.671 0.607 . . . . 0.0 110.776 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 76.2 m -89.59 -163.74 1.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.57 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 71.68 0.7 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.104 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -90.73 157.67 17.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.61 -169.92 14.7 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.53 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.03 99.76 1.18 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.269 -0.491 . . . . 0.0 111.971 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.5 100.44 0.34 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.27 136.39 27.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -154.38 80.03 4.81 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.96 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.03 -43.3 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.681 2.254 . . . . 0.0 112.237 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -89.86 -26.22 20.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.474 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.9 mt 71.78 86.58 0.11 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.704 0.627 . . . . 0.0 109.749 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 2.91 6.86 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.946 2.43 . . . . 0.0 113.258 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -80.55 103.51 10.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.065 0.46 . . . . 0.0 109.826 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.7 1.25 53.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 CA-C-O 118.294 -1.281 . . . . 0.0 110.27 -176.171 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 58.3 45.45 17.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.124 0.487 . . . . 0.0 110.327 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.43 169.62 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.511 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.434 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -76.4 -21.46 55.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.825 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -137.45 150.41 47.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.989 0.424 . . . . 0.0 110.768 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -104.46 -25.86 12.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -123.94 146.01 48.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.374 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.601 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 27' ' ' ILE . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 52' ' ' SER . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 m -122.51 150.39 42.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.5 mmp_? 59.63 54.15 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.402 0.62 . . . . 0.0 111.001 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.2 m -92.34 165.58 13.01 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.517 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.41 23.01 4.91 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -159.44 166.42 31.03 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.42 -57.21 0.44 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.44 -13.01 6.26 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.325 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.34 -37.91 1.81 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.807 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -163.36 -22.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.611 1.164 . . . . 0.0 110.27 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -74.73 120.6 82.35 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 63' ' ' ASN . 60.3 Cg_endo -74.15 96.72 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.829 2.353 . . . . 0.0 112.093 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 10.4 t30 76.99 1.73 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.342 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt 70.76 85.85 0.12 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.455 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -73.01 170.76 19.02 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.553 2.168 . . . . 0.0 110.334 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 m -85.31 159.79 19.96 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.458 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -81.39 -20.77 39.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.575 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.225 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 p -82.75 51.56 1.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.976 0.417 . . . . 0.0 111.383 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.44 147.6 38.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -77.51 -24.4 50.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.35 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.26 146.3 34.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.688 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -106.77 -15.63 14.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.412 0.625 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -114.72 144.46 43.42 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.362 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.439 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m -136.89 161.6 35.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.552 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.1 mmp_? 62.99 39.87 9.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 61.2 m -89.48 -170.76 2.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 49.94 3.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.734 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -115.47 -4.49 12.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 110.582 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 -66.65 3.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.288 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.88 -169.83 32.49 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.245 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 70.33 1.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.398 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.49 145.73 34.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.081 0.467 . . . . 0.0 110.778 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -125.06 107.1 28.24 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.933 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.65 -34.85 49.88 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.21 1.94 . . . . 0.0 111.512 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.53 -19.85 22.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.38 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.4 mt 54.57 86.52 0.16 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 123.36 0.413 . . . . 0.0 111.479 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.94 68.39 5.72 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.511 2.14 . . . . 0.0 112.794 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -72.81 -35.54 67.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 110.526 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -93.64 133.26 37.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.225 177.147 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.35 -178.902 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -80.24 74.5 7.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.12 0.486 . . . . 0.0 110.222 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.55 139.6 20.11 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.442 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.0 pt? -83.39 -35.35 25.15 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.453 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.12 118.18 29.46 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.843 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' HG23 ' A' ' 7' ' ' THR . 11.4 p90 -99.91 -26.65 13.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' CD2' ' A' ' 6' ' ' PHE . 19.5 p -123.87 168.25 13.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.505 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.535 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 28' ' ' SER . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 43' ' ' ARG . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 41' ' ' GLU . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' HA2' HH21 ' A' ' 42' ' ' ARG . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -125.49 152.57 44.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? 61.22 49.13 5.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.281 0.562 . . . . 0.0 110.379 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.4 m -90.19 156.38 18.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.048 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.82 28.45 12.24 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -100.41 76.95 1.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.637 -0.781 . . . . 0.0 109.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.62 119.92 5.0 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.818 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.09 -68.13 0.24 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.258 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.32 134.67 10.84 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.434 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.25 143.63 17.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.239 0.543 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.73 89.8 2.88 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.793 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.83 -39.14 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.662 2.241 . . . . 0.0 113.52 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.11 -17.61 49.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.162 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.5 mt 66.79 93.74 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.824 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.87 -18.61 52.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.532 2.155 . . . . 0.0 111.788 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -160.55 149.9 17.29 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.845 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 146.89 31.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.708 0.289 . . . . 0.0 110.617 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.189 0 CA-C-O 118.991 -0.894 . . . . 0.0 111.146 178.771 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.66 37.63 4.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.337 0.589 . . . . 0.0 110.032 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.12 142.69 44.29 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.576 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.2 pt? -77.81 -47.85 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.105 0.479 . . . . 0.0 110.004 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 20.9 m-20 -91.75 95.52 9.92 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 7' ' ' THR . 11.7 p90 -95.48 -17.83 21.16 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 6' ' ' PHE . 9.4 p -124.53 160.43 28.38 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.997 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -137.59 162.56 33.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 53' ' ' ARG . 10.4 mmt180 64.67 42.92 4.47 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.429 0.456 . . . . 0.0 110.547 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.7 m -83.79 135.86 34.37 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.31 26.62 69.89 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -171.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -155.25 170.61 21.46 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.327 -0.937 . . . . 0.0 110.196 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.89 -176.13 46.71 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 -122.65 0.63 Allowed Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.79 -44.08 91.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.333 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.91 165.55 24.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.797 0.332 . . . . 0.0 110.372 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -79.12 126.07 82.46 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.767 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.36 87.51 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.759 2.306 . . . . 0.0 111.907 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t30 70.5 3.71 4.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.545 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mp 65.04 93.56 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 111.12 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.76 -171.57 1.0 Allowed 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.637 2.224 . . . . 0.0 112.284 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -82.13 130.02 34.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -23.61 20.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.44 0.638 . . . . 0.0 109.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.144 0 CA-C-O 118.061 -1.411 . . . . 0.0 110.862 -179.46 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p 49.37 27.17 1.85 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.801 0.84 . . . . 0.0 112.832 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.3 162.72 15.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.588 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.508 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.7 pt? -74.95 -26.4 59.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.568 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -141.91 151.71 42.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -99.54 -21.38 15.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -124.05 145.52 49.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 17' ' ' LEU . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD2' HG22 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m -126.69 151.85 47.56 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.6 mmp_? 61.19 52.7 3.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.347 0.594 . . . . 0.0 111.246 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.2 m -90.75 158.05 17.08 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.507 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.58 -55.83 11.09 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.096 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 57.82 78.1 0.25 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.405 0.622 . . . . 0.0 110.542 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.68 60.14 0.25 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.68 84.05 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.232 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.7 171.36 38.11 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.031 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -84.62 -32.28 23.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.227 0.537 . . . . 0.0 109.888 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -127.48 93.19 41.3 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.53 -35.03 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.394 2.063 . . . . 0.0 112.659 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -90.51 -24.46 20.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt 70.27 86.93 0.11 Allowed Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.007 0.523 . . . . 0.0 111.525 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -88.93 65.21 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.896 2.397 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -157.54 157.37 33.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.122 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -84.56 -61.1 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 0.0 110.426 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.62 0 CA-C-O 118.054 -1.414 . . . . 0.0 110.722 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -102.68 93.86 5.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.014 0.435 . . . . 0.0 111.166 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.52 132.25 55.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.609 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -77.24 -42.98 35.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.42 149.35 37.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.834 0.349 . . . . 0.0 110.718 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 7' ' ' THR . 12.4 p90 -108.62 -31.38 7.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.48 HG23 ' CD2' ' A' ' 6' ' ' PHE . 11.6 p -122.24 152.34 40.12 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.381 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HD2' HG22 ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.592 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m -128.67 153.56 47.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 1.5 mmp_? 62.72 48.68 4.1 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.553 0.533 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.7 m -91.53 -179.13 5.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.979 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.74 109.94 3.15 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.862 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -153.2 148.56 27.03 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.95 104.8 2.25 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.9 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.219 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.52 -76.6 2.22 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.685 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.73 -175.55 5.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 65' ' ' PRO . 82.3 m95 -136.89 130.19 17.53 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.9 -46.52 28.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.835 2.357 . . . . 0.0 113.277 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -137.27 24.52 2.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.446 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.4 mt 54.2 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.117 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 94.7 Cg_endo -78.55 60.45 7.59 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.722 2.281 . . . . 0.0 112.043 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -83.38 157.79 22.38 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -85.21 -41.81 15.28 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.629 178.237 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -96.74 92.66 6.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.5 140.18 14.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.822 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.647 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.0 pt? -82.84 -44.81 15.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.782 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 32.8 m-20 -98.01 123.4 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.743 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.65 -20.72 14.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.33 0.586 . . . . 0.0 110.256 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -123.4 158.59 30.79 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.307 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 47' ' ' PRO . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.577 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.647 ' CZ ' ' HA ' ' A' ' 53' ' ' ARG . 2.9 mmp_? 59.84 46.74 10.96 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.517 0.675 . . . . 0.0 110.56 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.8 m -92.97 163.32 13.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.261 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.03 35.02 4.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.474 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -96.7 -153.77 0.42 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.61 108.23 0.67 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.29 -142.17 17.4 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.934 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.56 36.04 1.8 Allowed Glycine 0 C--N 1.316 -0.573 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.99 -179.36 7.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.169 0.509 . . . . 0.0 111.401 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -99.22 106.44 38.71 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.94 -56.72 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.44 2.093 . . . . 0.0 112.994 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -83.54 -9.12 59.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.068 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.5 mt 62.6 80.1 0.25 Allowed Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.073 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.86 165.01 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.543 2.162 . . . . 0.0 113.015 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 t -86.1 -160.01 0.51 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.247 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -94.43 -65.88 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 118.296 -1.28 . . . . 0.0 111.813 178.775 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.016 -0.433 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m 64.96 18.87 11.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.977 0.511 . . . . 0.0 111.177 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.23 164.37 38.43 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.18 0.514 . . . . 0.0 111.743 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.7 pt? -74.47 -21.73 59.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.293 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.11 151.41 43.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.757 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -111.76 -14.99 13.5 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.464 0.65 . . . . 0.0 109.885 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.1 131.63 54.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.284 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.514 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.512 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.427 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.5 mmt180 60.65 47.78 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.541 0.686 . . . . 0.0 109.565 -175.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.6 m -101.55 136.77 40.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.244 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.84 -77.46 0.21 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -83.56 -168.02 1.94 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.04 58.54 13.14 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 118.239 -1.934 . . . . 0.0 108.78 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.6 163.37 36.93 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 114.613 -0.794 . . . . 0.0 111.301 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.33 3.38 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG3' ' HD3' ' A' ' 62' ' ' PRO . 5.7 tp10 -165.71 162.19 18.57 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.081 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.629 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 32.6 p90 -162.18 63.81 1.56 Allowed Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.134 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 91.9 Cg_endo -93.72 3.11 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.822 2.348 . . . . 0.0 112.263 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -146.42 9.91 1.09 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.57 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.7 mt 71.73 107.31 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.978 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 73.8 Cg_endo -85.64 51.07 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.018 2.479 . . . . 0.0 112.491 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -79.9 -5.38 55.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.283 0.563 . . . . 0.0 110.8 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -88.91 -174.96 4.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.734 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.145 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.329 177.943 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -83.67 69.63 10.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.069 0.461 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.79 147.56 26.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.751 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 4' ' ' LEU . 1.3 pt? -80.3 -31.82 38.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.39 145.92 50.77 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -106.54 -24.45 12.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.781 0.8 . . . . 0.0 108.888 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' PRO . 4.8 t -123.91 153.8 40.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.704 177.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.543 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG22 ' HD2' ' A' ' 31' ' ' LYS . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' HG22 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.731 ' O ' HG21 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m -125.68 152.65 44.97 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 62.03 51.2 3.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.198 0.523 . . . . 0.0 109.962 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 51' ' ' CYS . 71.1 m -99.21 159.83 14.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.822 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.91 124.03 22.84 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -151.1 154.03 36.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 117.253 0.526 . . . . 0.0 110.826 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.47 -77.7 0.11 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.41 19.32 79.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.286 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.06 -146.28 21.91 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.968 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -156.52 153.6 29.0 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 6.2 m-90 -136.81 86.92 20.63 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.02 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.35 -59.62 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.324 2.016 . . . . 0.0 111.991 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.26 6.59 44.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.174 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 82.3 mt 57.84 71.39 1.07 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.14 99.88 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.636 2.224 . . . . 0.0 111.475 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -154.99 157.21 37.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -84.18 -30.95 25.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.169 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.426 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -80.78 91.88 5.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.723 0.296 . . . . 0.0 110.862 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.67 149.06 14.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -77.74 -27.01 50.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -125.66 149.46 48.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.71 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -102.94 -27.06 12.86 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -123.94 134.71 53.46 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.691 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m -130.94 152.98 49.67 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 59.07 52.27 6.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 70.8 m -86.84 -169.82 2.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.282 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.03 83.35 0.09 OUTLIER Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.649 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -86.71 25.79 1.21 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 122.894 0.478 . . . . 0.0 111.652 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.73 -98.06 0.51 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.481 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.92 36.49 0.53 Allowed Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.679 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.68 -143.72 16.68 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.408 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.68 -36.16 13.77 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HB2' HD23 ' A' ' 64' ' ' LEU . 90.0 m95 -145.13 132.34 10.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.65 -39.42 83.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.246 2.631 . . . . 0.0 113.515 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.58 13.6 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.025 0.441 . . . . 0.0 111.107 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 61' ' ' TRP . 61.1 mt 60.29 84.53 0.2 Allowed Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.357 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 98.3 Cg_endo -87.24 -1.47 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.472 2.115 . . . . 0.0 111.931 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -79.87 141.8 35.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.001 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 2.4 mmp_? -87.51 -17.54 31.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.796 0.331 . . . . 0.0 111.168 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.486 0 CA-C-O 118.809 -0.995 . . . . 0.0 111.756 -179.525 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -123.97 23.21 8.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.454 0.645 . . . . 0.0 109.992 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.36 108.38 19.98 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.664 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -81.34 -37.66 27.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.916 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -105.67 141.25 37.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -106.34 -29.4 9.78 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.023 0.44 . . . . 0.0 110.607 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -124.12 145.89 48.99 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.007 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.462 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.491 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -127.24 153.58 45.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.581 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 mmp_? 58.34 55.87 4.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 111.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.3 m -90.05 154.48 19.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 51.54 3.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.917 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -72.66 -43.71 62.8 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.963 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.29 100.44 2.44 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.867 -1.159 . . . . 0.0 111.87 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.6 -17.74 1.19 Allowed Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.93 67.6 1.81 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.9 131.75 35.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -136.89 86.15 21.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.616 0.246 . . . . 0.0 110.679 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.59 88.84 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.639 2.226 . . . . 0.0 111.04 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 61.15 35.59 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt 68.46 105.57 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.133 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.41 34.44 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.224 2.616 . . . . 0.0 113.682 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 m -149.63 147.58 28.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.35 . . . . 0.0 110.999 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.82 169.03 20.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.39 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.418 -1.212 . . . . 0.0 111.632 -179.776 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -80.19 96.55 6.6 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.369 0.604 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.03 149.49 24.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -79.04 -27.39 43.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.94 0.4 . . . . 0.0 110.333 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.43 147.82 33.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -102.31 -25.56 13.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.027 0.441 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -123.7 152.08 42.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.216 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m -134.74 156.69 48.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 22.1 mmt180 59.0 54.94 4.72 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 121.389 0.614 . . . . 0.0 111.323 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 81.0 m -91.48 149.5 21.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.513 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.92 -96.37 0.59 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.326 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -132.41 -53.58 0.95 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.59 -113.29 0.45 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.75 -50.94 0.54 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.602 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.59 74.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.815 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.74 174.04 15.64 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.73 0.3 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -144.99 87.22 7.33 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-O 121.471 0.653 . . . . 0.0 111.209 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.2 -24.05 8.39 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.804 2.336 . . . . 0.0 112.666 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.85 -21.72 31.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.3 mt 64.66 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.158 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.64 171.53 16.57 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.158 1.906 . . . . 0.0 110.747 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -76.66 96.55 4.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -83.06 129.03 34.99 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.544 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.093 0 CA-C-O 118.206 -1.33 . . . . 0.0 110.574 177.527 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m -90.59 19.13 5.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.455 0.645 . . . . 0.0 111.272 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.26 165.9 13.67 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.775 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.63 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.5 pt? -82.62 -47.91 11.54 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.845 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.447 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 1.6 m-20 -94.91 132.04 40.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.052 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 7' ' ' THR . 18.6 p90 -102.97 -27.79 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 HG23 ' CD2' ' A' ' 6' ' ' PHE . 7.3 p -122.25 154.26 37.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.805 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.578 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m -139.28 160.2 40.38 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.3 mmp_? 57.78 64.98 1.41 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.09 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.2 m -87.2 145.06 26.55 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.81 -82.63 0.27 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.741 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.24 175.86 10.52 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.442 0.639 . . . . 0.0 112.272 -173.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.91 145.62 12.38 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.04 61.77 1.4 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.501 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.74 42.3 1.39 Allowed Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -149.0 146.54 27.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -146.02 78.1 11.66 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 87.79 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.149 1.899 . . . . 0.0 111.477 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 t30 57.01 46.14 19.87 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.9 pp 46.11 103.71 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.344 1.057 . . . . 0.0 113.223 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.82 158.31 55.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.194 1.929 . . . . 0.0 112.201 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.5 m -81.49 -1.59 46.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.38 0.609 . . . . 0.0 110.408 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -85.84 113.62 22.13 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.752 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.446 0 CA-C-O 118.331 -1.26 . . . . 0.0 111.695 -179.383 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 47' ' ' PRO . 2.7 t . . . . . 0 N--CA 1.439 -1.001 0 CA-C-O 120.901 0.382 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.559 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 11' ' ' ARG . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.44 -0.965 0 CA-C-O 120.703 0.287 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.468 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m . . . . . 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.685 HG21 ' O ' ' A' ' 47' ' ' PRO . 5.1 t . . . . . 0 N--CA 1.436 -1.151 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.503 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.476 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.685 ' O ' HG21 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m . . . . . 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.98 0.419 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.653 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 31' ' ' LYS . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.454 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 47' ' ' PRO . 3.3 t . . . . . 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.453 ' CE ' ' HB3' ' A' ' 40' ' ' CYS . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.642 ' O ' HG21 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.5 p . . . . . 0 N--CA 1.436 -1.144 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.453 HG22 ' HD2' ' A' ' 31' ' ' LYS . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.487 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 120.712 0.292 . . . . 0.0 110.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.439 -1.003 0 CA-C-O 120.718 0.294 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.601 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 27' ' ' ILE . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 52' ' ' SER . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 m . . . . . 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.436 -1.13 0 CA-C-O 121.053 0.454 . . . . 0.0 111.362 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.439 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m . . . . . 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 19.5 p . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.535 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HD2' HG22 ' A' ' 27' ' ' ILE . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 43' ' ' ARG . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 41' ' ' GLU . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' HA2' HH21 ' A' ' 42' ' ' ARG . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 p . . . . . 0 N--CA 1.431 -1.375 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 CA--C 1.518 -0.252 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 17' ' ' LEU . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD2' HG22 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p . . . . . 0 N--CA 1.443 -0.808 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HD2' HG22 ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.592 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m . . . . . 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.44 -0.975 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 47' ' ' PRO . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.577 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t . . . . . 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.442 -0.866 0 CA-C-O 121.143 0.497 . . . . 0.0 111.284 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.514 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.512 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p . . . . . 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' PRO . 4.8 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.543 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG22 ' HD2' ' A' ' 31' ' ' LYS . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' HG22 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.731 ' O ' HG21 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.489 0.185 . . . . 0.0 110.691 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.446 -0.645 0 CA-C-O 120.677 0.275 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.462 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.491 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m . . . . . 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p . . . . . 0 N--CA 1.448 -0.528 0 CA-C-O 120.798 0.333 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.548 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m . . . . . 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.431 -1.392 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.578 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.157 0 N-CA-C 111.949 -0.461 . . . . 0.0 111.949 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.9 m -76.19 96.71 3.95 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.0 0.429 . . . . 0.0 110.187 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.48 154.12 49.07 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.428 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.627 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.5 pt? -77.49 -31.77 53.83 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.179 -179.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -138.51 147.54 43.26 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.142 0.496 . . . . 0.0 111.056 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -107.93 -19.94 13.35 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.355 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 47' ' ' PRO . 2.7 t -119.88 150.19 40.87 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.488 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.4 m -66.44 -22.57 66.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.927 -177.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 63.5 m -105.62 16.04 26.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.06 -33.32 74.18 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.403 0.62 . . . . 0.0 110.69 177.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.559 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.15 -8.77 25.98 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.255 -179.445 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.422 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 8.7 ptp -55.28 -20.06 10.16 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 177.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -109.28 26.76 10.25 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 121.248 0.547 . . . . 0.0 110.089 -179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -109.31 23.25 14.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.444 0.64 . . . . 0.0 109.397 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.43 -179.53 37.54 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.642 -0.708 . . . . 0.0 112.266 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.52 -38.14 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 122.411 0.285 . . . . 0.0 111.528 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -63.64 -44.26 94.39 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.73 -38.59 92.21 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.119 178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.32 -43.09 78.65 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 122.398 0.279 . . . . 0.0 111.602 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -69.47 -41.78 75.74 Favored 'General case' 0 CA--C 1.51 -0.58 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.046 179.145 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HG3' ' A' ' 11' ' ' ARG . 43.2 t -62.05 -43.85 98.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.234 0.54 . . . . 0.0 109.611 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.2 -55.46 34.64 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.455 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.569 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.7 pt20 -61.1 -41.4 96.6 Favored 'General case' 0 C--O 1.217 -0.614 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.732 -178.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.62 -48.66 76.4 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.872 0.367 . . . . 0.0 110.624 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.51 -37.06 82.33 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.766 178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.528 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -70.38 -53.27 17.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.849 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 80.5 mt -57.24 -47.86 83.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.733 -178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 p -57.8 -49.53 76.31 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.512 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.4 p -61.83 -33.07 73.5 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-O 120.741 0.305 . . . . 0.0 111.584 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 96.3 m -68.37 -45.5 72.6 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 120.955 0.407 . . . . 0.0 110.921 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.599 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.3 mtpm? -56.25 -42.57 77.58 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.777 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -61.66 -29.58 70.16 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -98.54 17.48 18.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.865 0.364 . . . . 0.0 111.494 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.9 t30 69.98 49.32 0.5 Allowed 'General case' 0 C--O 1.24 0.561 0 CA-C-O 121.694 0.759 . . . . 0.0 110.976 176.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 85.3 m -121.21 134.84 55.21 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.56 176.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -53.88 -41.58 67.7 Favored Glycine 0 CA--C 1.504 -0.632 0 CA-C-N 115.572 -0.74 . . . . 0.0 113.067 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -158.08 -178.8 7.57 Favored 'General case' 0 N--CA 1.433 -1.324 0 CA-C-O 120.966 0.413 . . . . 0.0 111.016 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -147.82 148.61 20.31 Favored Glycine 0 N--CA 1.431 -1.696 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.19 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -147.94 148.56 30.91 Favored 'General case' 0 C--N 1.308 -1.196 0 CA-C-O 120.943 0.401 . . . . 0.0 109.983 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.429 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 61.9 m -83.1 122.42 28.33 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -129.98 136.07 49.02 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.36 -178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.451 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 9.7 mtp180 -91.42 124.26 35.47 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.225 0.535 . . . . 0.0 110.934 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -127.32 117.47 22.31 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.04 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.27 42.75 95.62 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.209 -176.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.451 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 74.02 -5.12 27.38 Favored Glycine 0 C--O 1.227 -0.295 0 C-N-CA 121.27 -0.49 . . . . 0.0 113.408 -178.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 72.2 mmt-85 -94.51 116.79 66.79 Favored Pre-proline 0 C--N 1.311 -1.108 0 N-CA-C 111.635 0.235 . . . . 0.0 111.635 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 56.1 Cg_endo -71.29 98.11 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.456 2.104 . . . . 0.0 110.655 176.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.5 152.96 26.87 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.579 -173.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.6 t -92.09 115.04 27.73 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.4 m -114.87 126.53 72.46 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.36 0 CA-C-O 121.394 0.616 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 56.8 m -86.1 142.45 28.68 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.503 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.3 m -114.31 143.3 45.1 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.612 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 58.5 65.27 1.28 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.639 -0.709 . . . . 0.0 111.734 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.5 m -94.43 153.84 17.75 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.697 178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.61 -54.14 38.14 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.369 -0.92 . . . . 0.0 111.767 -179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -113.25 100.28 8.45 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 142.43 -22.03 2.39 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.211 -0.995 . . . . 0.0 112.73 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.8 -113.94 3.74 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.918 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -170.79 -79.96 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.787 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -160.22 151.23 19.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.621 0.248 . . . . 0.0 110.58 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -147.0 77.72 10.83 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.4 -35.07 19.09 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.663 2.242 . . . . 0.0 112.113 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -90.89 -17.29 26.73 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.0 mp 59.36 87.13 0.14 Allowed Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.533 -176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.93 -171.4 1.24 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.813 2.342 . . . . 0.0 112.4 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.4 p -84.23 176.2 8.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.859 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.652 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 0.3 OUTLIER -84.43 -52.5 6.12 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.553 -179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.884 -0.953 . . . . 0.0 111.326 -179.407 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.368 0 N-CA-C 112.054 -0.418 . . . . 0.0 112.054 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.2 p -108.52 97.45 7.11 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.07 0.462 . . . . 0.0 111.298 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.18 143.13 50.75 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.881 179.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.634 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.7 pt? -97.39 7.28 46.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.938 0.875 . . . . 0.0 109.303 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -150.09 162.75 39.8 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.045 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -102.52 -20.65 14.41 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.375 0.607 . . . . 0.0 109.391 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 t -124.44 137.48 54.44 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.398 178.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.6 m -59.76 -17.93 39.13 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.9 m -100.62 8.88 43.14 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.68 -30.69 71.76 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.0 0.428 . . . . 0.0 110.892 178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -9.53 34.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.074 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.46 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.9 ptp -56.44 -16.22 5.44 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 120.582 0.23 . . . . 0.0 110.649 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -108.84 21.96 16.55 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.78 0.324 . . . . 0.0 110.504 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.468 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 15.2 t70 -107.21 19.92 19.69 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.356 0.598 . . . . 0.0 109.687 -177.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.01 179.56 30.25 Favored Glycine 0 N--CA 1.438 -1.207 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.092 -178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.428 ' O ' ' HE2' ' A' ' 20' ' ' LYS . . . -53.7 -39.81 65.49 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -68.68 -41.7 78.85 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.3 -41.51 95.04 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.847 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.1 -40.7 77.51 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.767 0.318 . . . . 0.0 111.351 178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.428 ' HE2' ' O ' ' A' ' 16' ' ' ALA . 0.8 OUTLIER -70.48 -41.46 72.69 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 179.163 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 17' ' ' LEU . 75.7 t -59.98 -46.67 93.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.171 0.51 . . . . 0.0 109.919 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.63 -53.21 60.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.543 178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.431 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.3 pt20 -61.77 -39.29 91.14 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.926 -178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.77 -48.46 79.08 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.007 0.432 . . . . 0.0 110.611 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.14 -35.27 78.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.858 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.5 t -73.09 -51.67 17.18 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.057 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 23' ' ' GLN . 82.4 mt -58.48 -47.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.249 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.4 p -58.01 -50.41 73.51 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 123.085 0.241 . . . . 0.0 111.23 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 p -61.84 -34.12 75.39 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.718 0.294 . . . . 0.0 111.7 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.479 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -67.31 -45.46 76.45 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.048 0.452 . . . . 0.0 110.29 178.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -55.13 -45.24 75.57 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.214 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -58.75 -30.25 67.37 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -98.46 17.01 19.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.782 0.325 . . . . 0.0 111.188 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 67.52 42.58 2.08 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.669 0.788 . . . . 0.0 111.683 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 57.6 m -107.87 138.47 44.06 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 176.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.0 -46.09 94.77 Favored Glycine 0 C--N 1.321 -0.282 0 O-C-N 123.595 0.559 . . . . 0.0 113.678 -176.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.2 t -155.12 140.01 17.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.079 0.466 . . . . 0.0 111.764 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.479 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -110.48 149.22 17.62 Favored Glycine 0 N--CA 1.438 -1.186 0 C-N-CA 120.856 -0.687 . . . . 0.0 111.934 177.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.1 p-80 -149.43 147.17 27.94 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.057 0.456 . . . . 0.0 110.218 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.405 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 80.7 m -84.65 124.71 31.78 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -133.71 139.95 46.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.97 -177.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -90.54 124.61 35.15 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.194 0.521 . . . . 0.0 110.425 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.33 119.49 24.0 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.065 -0.97 . . . . 0.0 108.9 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.18 42.17 97.04 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 -174.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.24 -6.9 6.67 Favored Glycine 0 C--N 1.339 0.711 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.419 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.5 mtt180 -94.66 115.68 65.58 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 52.9 Cg_endo -69.85 98.93 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.686 2.257 . . . . 0.0 110.904 177.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.0 m -110.74 153.61 25.06 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.163 -173.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.415 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 12.4 t -90.45 109.47 20.59 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 176.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 m -113.84 127.87 71.02 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.347 0.594 . . . . 0.0 110.906 -178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 35.0 m -93.14 155.76 17.27 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.482 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 40.7 m -137.85 162.62 33.51 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 177.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.6 mmm180 60.38 44.33 12.35 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.591 0.71 . . . . 0.0 109.579 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.5 m -91.64 163.46 14.1 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.997 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.52 48.29 57.83 Favored Glycine 0 N--CA 1.441 -0.981 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.55 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -100.23 83.52 2.68 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 -177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -157.29 164.37 32.89 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.76 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.93 141.02 5.33 Favored Glycine 0 N--CA 1.445 -0.702 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 76.5 -61.38 3.2 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 121.001 -0.618 . . . . 0.0 111.94 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -154.26 168.11 27.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 m-90 -84.1 137.66 40.05 Favored Pre-proline 0 C--N 1.312 -1.03 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.986 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -65.46 -43.56 10.35 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.707 2.271 . . . . 0.0 111.881 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -145.84 10.56 1.2 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.995 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.4 mp 62.11 80.67 0.25 Allowed Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.557 -177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -96.43 26.02 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.118 0 C-N-CA 123.182 2.588 . . . . 0.0 110.93 178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 6.8 p -161.36 -177.76 6.21 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.373 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.31 168.2 28.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.327 -0.619 . . . . 0.0 109.327 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.8 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 111.786 -0.526 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 p -94.64 9.43 38.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.134 0.492 . . . . 0.0 110.81 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.17 161.56 41.75 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.499 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.669 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.0 pt? -76.7 -42.72 40.49 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.402 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.47 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 3.7 m-20 -90.1 108.24 19.61 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.891 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -95.62 -21.13 18.42 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.686 0.755 . . . . 0.0 109.362 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.685 HG21 ' O ' ' A' ' 47' ' ' PRO . 5.1 t -124.22 151.92 43.54 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 114.789 -1.096 . . . . 0.0 109.152 177.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.9 m -61.27 -22.25 64.66 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 111.789 0.292 . . . . 0.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.8 m -107.08 16.18 24.44 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -176.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -64.76 -31.13 72.22 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.663 0.744 . . . . 0.0 110.466 178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.503 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.54 -9.7 37.66 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.95 179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -54.82 -20.91 9.64 Favored 'General case' 0 N--CA 1.474 0.775 0 CA-C-O 120.503 0.192 . . . . 0.0 111.208 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -115.89 28.99 8.27 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-O 121.418 0.628 . . . . 0.0 110.246 -178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -103.41 9.97 37.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.378 -0.828 . . . . 0.0 108.901 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.65 173.13 18.91 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.161 -176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.84 -35.42 57.37 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.55 -37.52 77.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.29 -38.95 95.4 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.43 -0.805 . . . . 0.0 112.391 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.69 -34.34 72.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 121.249 0.547 . . . . 0.0 110.681 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.549 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 2.9 tppt? -72.45 -43.83 63.22 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.916 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 48.5 t -63.12 -44.11 99.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.938 178.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.81 -55.55 33.4 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.494 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.549 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 14.8 pt20 -61.12 -39.21 89.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -177.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.22 69.54 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 120.937 0.398 . . . . 0.0 110.563 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.11 -35.52 80.56 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.582 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 34.0 t -71.04 -54.38 11.4 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.14 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 95.7 mt -55.78 -51.95 54.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.071 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.2 m -59.0 -44.29 91.65 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.565 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 60.0 m -62.78 -37.64 87.45 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 111.162 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.444 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.7 m -66.42 -47.99 71.46 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.447 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -58.01 -41.44 83.14 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.519 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -59.49 -35.22 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.846 -0.615 . . . . 0.0 112.041 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.476 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.8 pt20 -94.03 16.69 13.89 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 111.225 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.6 t30 69.81 48.36 0.57 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 122.088 0.947 . . . . 0.0 111.335 177.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' SG ' ' HG3' ' A' ' 33' ' ' GLN . 88.2 m -114.85 135.46 54.17 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.287 -0.869 . . . . 0.0 109.074 175.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -52.4 -42.7 57.29 Favored Glycine 0 C--N 1.321 -0.263 0 O-C-N 123.712 0.633 . . . . 0.0 113.013 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.3 t -158.49 176.73 12.05 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 120.597 -0.441 . . . . 0.0 111.625 178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.15 145.88 15.35 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.199 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.13 151.61 33.42 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-O 120.964 0.411 . . . . 0.0 109.969 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.431 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 74.6 m -86.24 123.24 31.29 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.809 -179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -134.56 144.47 47.99 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.143 -177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 34.8 mtp180 -91.37 126.02 36.32 Favored 'General case' 0 CA--C 1.498 -1.055 0 CA-C-O 121.152 0.501 . . . . 0.0 110.13 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -129.54 117.49 20.54 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.071 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.32 44.32 97.65 Favored Glycine 0 N--CA 1.44 -1.082 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -173.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.94 -15.68 1.23 Allowed Glycine 0 C--N 1.342 0.871 0 C-N-CA 121.639 -0.315 . . . . 0.0 113.724 -176.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -90.19 117.76 68.3 Favored Pre-proline 0 C--N 1.302 -1.458 0 CA-C-O 120.78 0.324 . . . . 0.0 111.866 -175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.685 ' O ' HG21 ' A' ' 7' ' ' THR . 31.7 Cg_endo -65.35 123.1 11.0 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 122.26 1.974 . . . . 0.0 109.836 176.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.3 m -137.92 154.95 49.38 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 120.642 -0.423 . . . . 0.0 110.31 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 14.8 t -90.05 110.01 21.03 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 175.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.1 m -110.57 125.23 67.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.303 0 CA-C-O 121.46 0.647 . . . . 0.0 110.984 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 34.0 m -92.95 151.69 19.78 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.272 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.7 m -123.61 148.56 46.29 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.265 177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 53' ' ' ARG . 8.3 mmt180 63.02 51.81 2.74 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-O 121.342 0.591 . . . . 0.0 112.053 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.3 m -92.38 135.99 33.57 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.6 61.23 6.94 Favored Glycine 0 C--O 1.238 0.406 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.093 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -85.12 106.87 16.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.495 0.664 . . . . 0.0 111.165 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.46 122.82 0.62 Allowed Glycine 0 N--CA 1.439 -1.145 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.69 104.81 1.53 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.973 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -92.4 82.85 1.15 Allowed Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -154.5 164.53 38.54 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.187 0.517 . . . . 0.0 111.143 -176.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.482 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 23.3 p90 -137.54 69.08 53.48 Favored Pre-proline 0 C--N 1.311 -1.067 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.174 178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.29 -28.84 8.37 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.852 2.368 . . . . 0.0 112.324 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -91.96 -11.47 36.04 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.882 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 82.4 mt 68.6 123.41 0.03 OUTLIER Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.631 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.482 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 74.8 Cg_exo -51.02 174.21 0.07 OUTLIER 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.332 2.688 . . . . 0.0 112.848 177.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 74.5 m -161.12 89.23 0.77 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.961 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -85.33 169.74 13.44 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.674 177.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 176.501 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.142 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -102.04 34.61 2.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.038 0.447 . . . . 0.0 110.821 -178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.2 179.87 6.09 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.278 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.7 pt? -74.87 -34.13 62.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.877 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.561 ' CG ' ' HB3' ' A' ' 10' ' ' ALA . 33.9 t0 -130.89 134.4 46.74 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.7 p90 -99.08 -10.45 22.55 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.389 0.614 . . . . 0.0 109.446 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -122.97 172.4 8.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.534 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.653 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 18.5 m -81.12 -23.22 38.52 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 112.481 0.548 . . . . 0.0 112.481 174.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.406 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 56.1 m -113.58 13.72 18.8 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 -175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' CG ' ' A' ' 5' ' ' ASP . . . -73.17 -20.52 60.88 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 119.624 1.102 . . . . 0.0 111.257 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -63.46 -9.63 13.65 Favored 'General case' 0 C--O 1.218 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.779 176.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 ptp -55.69 -14.33 2.17 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.665 -0.243 . . . . 0.0 110.774 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.9 m-80 -105.24 21.84 16.43 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.812 0.339 . . . . 0.0 110.385 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 17.8 t70 -111.03 26.37 10.78 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.67 -173.34 43.57 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.097 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.92 -34.31 71.56 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 122.406 0.282 . . . . 0.0 111.348 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -66.82 -44.94 79.8 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.569 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.34 -44.47 96.55 Favored Glycine 0 CA--C 1.504 -0.596 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.826 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.22 -35.86 72.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.035 0.445 . . . . 0.0 110.279 177.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.406 ' HD3' ' OE1' ' A' ' 23' ' ' GLN . 0.3 OUTLIER -69.78 -44.61 69.77 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.943 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -62.24 -45.12 99.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 121.205 0.526 . . . . 0.0 109.902 177.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.566 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.78 -56.03 27.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.197 -0.91 . . . . 0.0 111.497 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.406 ' OE1' ' HD3' ' A' ' 20' ' ' LYS . 15.6 pt20 -61.28 -40.18 93.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.428 -177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.39 -49.9 73.69 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 120.975 0.417 . . . . 0.0 110.66 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.39 -32.54 74.2 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.604 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -73.51 -55.17 6.68 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.174 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.477 HG22 ' HD2' ' A' ' 31' ' ' LYS . 86.0 mt -55.59 -52.02 51.93 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.266 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.6 p -61.05 -42.98 99.5 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.728 0.299 . . . . 0.0 111.365 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.4 t -62.37 -38.18 88.57 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.901 0.381 . . . . 0.0 110.469 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.454 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 88.5 m -66.42 -50.6 62.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.941 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 4.1 mtpm? -57.89 -42.21 84.18 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.987 0.422 . . . . 0.0 110.851 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -60.07 -36.33 77.12 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.711 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.14 23.41 5.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.979 0.419 . . . . 0.0 111.197 -176.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.3 t30 71.26 46.04 0.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.519 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.57 ' O ' ' HA ' ' A' ' 31' ' ' LYS . 96.5 m -122.64 137.74 54.81 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.551 173.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.425 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -61.81 -40.07 98.33 Favored Glycine 0 C--N 1.317 -0.492 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.462 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -155.44 172.86 17.53 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.982 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.88 147.95 18.72 Favored Glycine 0 N--CA 1.433 -1.541 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.669 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.2 p-80 -150.45 152.27 34.01 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.566 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 62.0 m -85.46 126.28 33.69 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.462 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -141.15 145.13 35.32 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -88.79 124.03 33.77 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-O 121.185 0.517 . . . . 0.0 110.166 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -117.02 112.99 21.71 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.261 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.25 42.89 98.9 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.271 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.0 -4.07 33.4 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.323 -0.465 . . . . 0.0 113.268 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 5.4 mmp_? -100.37 111.83 63.25 Favored Pre-proline 0 C--N 1.311 -1.107 0 O-C-N 122.865 -0.197 . . . . 0.0 111.379 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 29.8 Cg_endo -63.28 106.05 0.54 Allowed 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 122.477 2.118 . . . . 0.0 111.462 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.5 m -119.82 156.66 30.22 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.796 -175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.1 t -91.66 105.1 17.48 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 175.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.5 m -102.47 127.06 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.141 0 CA-C-O 121.338 0.589 . . . . 0.0 110.532 -177.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.4 m -96.88 157.59 15.83 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.225 -177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.6 m -133.62 160.15 38.37 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.216 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.461 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 5.0 mmp_? 60.84 44.19 11.13 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.35 0.595 . . . . 0.0 110.068 -177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 73.8 m -93.07 156.41 16.89 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.554 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.73 -107.74 2.0 Allowed Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.849 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -92.43 132.59 36.65 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.34 -87.19 0.8 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.042 177.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.17 -110.1 3.44 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.901 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -124.16 144.7 15.55 Favored Glycine 0 N--CA 1.439 -1.111 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.136 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -157.67 173.63 16.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' HB2' HD23 ' A' ' 64' ' ' LEU . 29.8 m95 -92.8 126.85 50.14 Favored Pre-proline 0 C--N 1.31 -1.144 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.841 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -59.94 -48.27 12.93 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.438 2.092 . . . . 0.0 112.719 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -138.98 30.48 2.24 Favored 'General case' 0 N--CA 1.464 0.232 0 O-C-N 122.244 -0.285 . . . . 0.0 110.897 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD23 ' HB2' ' A' ' 61' ' ' TRP . 63.8 mt 53.52 92.25 0.06 OUTLIER Pre-proline 0 N--CA 1.477 0.894 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.49 143.74 22.04 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.109 1.873 . . . . 0.0 110.429 175.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 60.3 p -161.29 155.65 22.89 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.656 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -91.58 -14.46 30.22 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.586 0.708 . . . . 0.0 109.231 178.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.608 0 CA-C-O 118.832 -0.982 . . . . 0.0 110.69 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -92.26 97.67 11.03 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.793 0.33 . . . . 0.0 110.824 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -149.05 134.68 18.69 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.595 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -82.21 -33.05 29.51 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.999 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -133.34 143.21 48.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.922 0.391 . . . . 0.0 110.458 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -101.94 -21.35 14.54 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.187 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.642 HG21 ' O ' ' A' ' 47' ' ' PRO . 3.3 t -123.25 144.2 49.56 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.233 0.539 . . . . 0.0 111.817 -177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.9 m -59.9 -24.89 64.66 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.564 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 12' ' ' MET . 56.9 m -100.41 13.33 34.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.53 -31.4 72.17 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 121.194 0.521 . . . . 0.0 110.955 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.532 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -67.62 -9.51 43.71 Favored 'General case' 0 C--O 1.221 -0.404 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.188 -177.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.453 ' CE ' ' HB3' ' A' ' 40' ' ' CYS . 12.2 ptp -55.47 -16.23 3.55 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 120.641 0.258 . . . . 0.0 110.789 175.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -105.97 27.62 8.39 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 120.848 0.356 . . . . 0.0 110.057 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 34.9 t70 -117.7 22.05 12.58 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.587 0.708 . . . . 0.0 110.1 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.83 -173.85 35.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.519 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.402 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -59.08 -38.04 78.52 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 122.531 0.333 . . . . 0.0 111.593 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.524 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.68 -45.59 82.27 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 178.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.37 -44.88 96.26 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.825 177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.09 -37.47 71.96 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 120.848 0.356 . . . . 0.0 110.482 177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.402 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.3 -46.73 72.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.073 177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.3 t -60.91 -44.9 98.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.072 0.463 . . . . 0.0 110.147 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.525 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.19 -55.76 30.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.411 178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.449 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.4 pt20 -61.69 -40.68 95.86 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.956 -178.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.08 76.64 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.779 0.323 . . . . 0.0 110.746 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.8 -36.63 81.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.867 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 20.8 t -72.6 -53.9 10.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.044 -177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 23' ' ' GLN . 94.5 mt -55.6 -50.79 64.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.134 -178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.9 p -58.51 -48.2 81.59 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.323 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.0 m -61.96 -34.36 75.99 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.104 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 86.2 m -67.96 -49.55 61.07 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 120.993 0.425 . . . . 0.0 110.588 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.42 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.7 mtpp -56.92 -39.99 75.52 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.275 179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -59.83 -32.86 71.05 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 177.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -98.49 25.23 6.55 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.0 t30 71.23 32.09 2.27 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.92 176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 88.4 m -106.45 138.14 43.16 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 176.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.92 -46.22 91.1 Favored Glycine 0 CA--C 1.507 -0.451 0 CA-C-N 116.091 -0.504 . . . . 0.0 112.902 -178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.4 t -156.4 -177.77 6.84 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-O 120.671 0.272 . . . . 0.0 110.535 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.96 152.2 24.06 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -149.48 148.45 29.42 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 120.994 0.426 . . . . 0.0 110.111 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 77.5 m -83.45 125.56 31.84 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.205 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -127.29 139.92 52.57 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.316 -178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.9 mtp180 -92.16 115.98 28.55 Favored 'General case' 0 CA--C 1.495 -1.164 0 CA-C-O 121.394 0.616 . . . . 0.0 109.949 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.0 mmm180 -106.22 102.78 12.17 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-N 115.089 -0.96 . . . . 0.0 108.615 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.72 50.8 62.42 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.042 -177.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.517 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 73.73 -13.6 4.0 Favored Glycine 0 C--O 1.222 -0.637 0 C-N-CA 121.373 -0.442 . . . . 0.0 114.051 -177.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 28.7 mmt180 -95.49 107.89 36.04 Favored Pre-proline 0 C--N 1.312 -1.038 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -176.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.642 ' O ' HG21 ' A' ' 7' ' ' THR . 37.9 Cg_exo -61.28 127.92 23.46 Favored 'Trans proline' 0 C--O 1.216 -0.618 0 C-N-CA 122.634 2.223 . . . . 0.0 111.031 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -143.42 156.43 44.66 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 121.1 -0.24 . . . . 0.0 110.457 178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.2 t -89.55 113.55 24.98 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.6 m -116.12 128.45 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-O 121.211 0.529 . . . . 0.0 110.622 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.461 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 59.1 m -87.75 150.9 23.3 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.74 -177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 29.2 m -132.88 159.35 40.14 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.012 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 1.7 mmp_? 57.32 42.52 24.9 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 121.543 0.687 . . . . 0.0 109.878 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 13.7 t -104.67 170.46 7.87 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.564 -175.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.21 132.46 48.42 Favored Glycine 0 N--CA 1.433 -1.532 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 175.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -134.49 98.24 4.02 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.243 0.544 . . . . 0.0 110.633 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 68.46 -131.81 27.08 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.06 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.27 137.52 2.59 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 111.581 -0.608 . . . . 0.0 111.581 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -120.86 61.38 0.52 Allowed Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.762 -0.732 . . . . 0.0 111.988 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 1.1 pm0 -78.14 115.05 17.58 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.912 0.863 . . . . 0.0 111.511 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.427 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 5.5 m-90 -102.94 115.82 63.52 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 114.502 -1.226 . . . . 0.0 110.251 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 61' ' ' TRP . 19.6 Cg_endo -63.84 -63.21 0.08 OUTLIER 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.081 1.854 . . . . 0.0 112.037 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -88.62 -17.26 30.48 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.925 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 6.8 mp 64.27 98.16 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.508 0 CA-C-O 120.956 0.408 . . . . 0.0 111.904 -176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.58 85.79 0.72 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.475 2.117 . . . . 0.0 110.934 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.2 m -83.46 38.97 0.64 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.241 -178.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.43 144.98 23.28 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 120.704 0.288 . . . . 0.0 110.407 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.426 0 CA-C-O 118.44 -1.2 . . . . 0.0 111.028 178.787 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.004 0 N-CA-C 111.816 -0.514 . . . . 0.0 111.816 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 m -81.27 95.7 7.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.952 0.406 . . . . 0.0 110.763 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.14 174.66 9.05 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.415 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.577 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -78.63 -47.34 17.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.497 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -97.44 132.17 43.39 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.452 ' CD2' HG23 ' A' ' 7' ' ' THR . 33.4 p90 -103.8 -26.68 12.62 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.452 HG23 ' CD2' ' A' ' 6' ' ' PHE . 4.5 p -122.51 145.97 47.83 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.718 177.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 11' ' ' ARG . 4.4 m -61.18 -23.57 65.68 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.853 0.358 . . . . 0.0 111.364 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 67.1 m -102.68 13.97 33.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.13 -30.59 71.14 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.277 0.561 . . . . 0.0 110.905 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.517 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -65.65 -9.84 30.83 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.242 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 10.8 ptp -56.51 -17.39 8.18 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 122.328 -0.232 . . . . 0.0 110.873 177.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.8 m-80 -109.06 23.95 13.81 Favored 'General case' 0 C--N 1.34 0.19 0 CA-C-O 121.034 0.445 . . . . 0.0 109.911 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.431 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 8.1 t70 -108.19 14.74 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.306 0.574 . . . . 0.0 109.885 -177.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.91 -179.94 30.22 Favored Glycine 0 N--CA 1.441 -0.97 0 C-N-CA 120.571 -0.824 . . . . 0.0 112.483 -178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -50.11 -43.09 51.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -68.1 -39.33 82.84 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.8 -40.96 98.92 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.047 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.66 -40.23 75.14 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.662 0.267 . . . . 0.0 111.469 178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 -40.86 73.21 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.824 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 17' ' ' LEU . 48.8 t -62.03 -42.69 95.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.155 0.502 . . . . 0.0 109.669 178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.517 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.48 -56.16 25.75 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.605 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -61.43 -38.91 88.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.91 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.74 -47.52 80.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.485 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.87 -33.89 76.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.827 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.447 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 45.8 t -72.2 -52.16 17.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.086 -178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.453 HG22 ' HD2' ' A' ' 31' ' ' LYS . 96.2 mt -55.76 -50.18 69.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.855 -178.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.6 p -58.53 -47.02 85.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.848 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.9 t -59.83 -39.51 85.34 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.669 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.487 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.8 m -65.94 -47.32 75.06 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.743 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.453 ' HD2' HG22 ' A' ' 27' ' ' ILE . 22.9 mtpp -59.46 -40.17 86.03 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.883 179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -61.13 -33.41 73.33 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -95.15 16.8 15.52 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.843 0.354 . . . . 0.0 111.497 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 70.75 48.54 0.42 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.28 176.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 96.0 m -120.58 135.37 55.11 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.118 176.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.01 -37.43 92.71 Favored Glycine 0 C--N 1.32 -0.318 0 CA-C-N 115.569 -0.742 . . . . 0.0 114.057 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.8 t -151.7 163.02 40.02 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.022 0.439 . . . . 0.0 111.419 -178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.19 144.59 13.64 Favored Glycine 0 N--CA 1.432 -1.572 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.495 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -150.34 153.21 35.68 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 77.8 m -85.71 126.73 34.19 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.605 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -139.04 145.09 39.17 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.326 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' NH2' ' HA2' ' A' ' 45' ' ' GLY . 18.9 mtp180 -85.18 117.9 24.42 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.695 -178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -109.98 105.7 14.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.156 178.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.3 52.16 49.36 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.793 -178.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 80.6 -19.98 6.69 Favored Glycine 0 N--CA 1.461 0.32 0 C-N-CA 121.214 -0.517 . . . . 0.0 113.314 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.43 ' HD2' ' CE2' ' A' ' 6' ' ' PHE . 38.1 mmt180 -90.46 115.08 63.32 Favored Pre-proline 0 C--N 1.31 -1.125 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -176.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 46' ' ' ARG . 38.2 Cg_endo -67.89 97.09 0.46 Allowed 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.405 2.07 . . . . 0.0 110.559 176.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -114.62 156.91 23.83 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.331 -173.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.1 t -90.22 113.71 25.57 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.1 m -109.77 125.57 66.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-O 121.526 0.679 . . . . 0.0 110.558 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.9 m -95.35 152.31 18.5 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.447 -178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.4 t -133.76 161.56 34.39 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.088 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 61.29 45.91 8.32 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.36 0.6 . . . . 0.0 110.088 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 75.9 m -86.66 140.5 29.76 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.736 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.37 45.45 6.52 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.164 -1.017 . . . . 0.0 111.966 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 53.11 30.53 9.82 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 164.05 -49.01 0.3 Allowed Glycine 0 CA--C 1.509 -0.295 0 C-N-CA 119.907 -1.14 . . . . 0.0 112.872 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.93 1.08 61.66 Favored Glycine 0 C--O 1.237 0.304 0 C-N-CA 120.63 -0.795 . . . . 0.0 113.356 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.53 -112.02 4.33 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.39 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -83.83 168.89 15.71 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.686 0.243 . . . . 0.0 110.424 177.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.604 ' CD1' ' HD2' ' A' ' 65' ' ' PRO . 22.0 m-90 58.73 52.17 4.26 Favored Pre-proline 0 CA--C 1.547 0.855 0 O-C-N 123.667 0.604 . . . . 0.0 111.884 -178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 61' ' ' TRP . 10.9 Cg_exo -71.93 -19.18 27.22 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.401 2.067 . . . . 0.0 111.969 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -130.33 13.3 5.56 Favored 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 28.1 mt 51.62 68.84 2.9 Favored Pre-proline 0 CA--C 1.542 0.655 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.719 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.604 ' HD2' ' CD1' ' A' ' 61' ' ' TRP . 53.1 Cg_exo -58.16 133.27 54.27 Favored 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.067 1.845 . . . . 0.0 110.495 175.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.3 t -86.43 17.44 3.79 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.23 170.28 22.21 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.713 -1.048 . . . . 0.0 111.032 177.509 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.73 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.1 m -135.55 24.02 3.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.407 0.622 . . . . 0.0 109.992 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -79.5 111.31 15.64 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.468 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -74.22 -26.83 60.49 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.527 ' OD2' ' HB3' ' A' ' 10' ' ' ALA . 13.3 t0 -151.08 148.29 28.13 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 114.567 -1.197 . . . . 0.0 108.413 177.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.468 ' CD2' HG23 ' A' ' 7' ' ' THR . 9.6 p90 -97.89 -24.09 15.56 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 120.958 0.409 . . . . 0.0 110.148 -178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.468 HG23 ' CD2' ' A' ' 6' ' ' PHE . 11.9 p -123.75 170.59 10.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.249 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 m -81.6 -30.11 33.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.87 0.367 . . . . 0.0 111.249 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.422 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 18.5 m -103.68 15.36 29.01 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 114.904 1.446 . . . . 0.0 114.904 -174.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' OD2' ' A' ' 5' ' ' ASP . . . -69.45 -17.44 63.63 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.523 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.42 -14.24 48.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.58 178.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.8 ptp -56.13 -17.63 7.71 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -113.78 27.92 9.16 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.138 0.494 . . . . 0.0 110.398 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.488 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.2 t70 -111.89 18.87 18.46 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.3 177.08 28.88 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.652 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.64 -32.1 70.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.96 0.41 . . . . 0.0 111.082 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -69.15 -42.87 75.39 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.37 -40.17 93.77 Favored Glycine 0 N--CA 1.444 -0.83 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.678 176.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.37 -38.29 76.95 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.326 0.584 . . . . 0.0 109.89 178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.43 -46.87 71.87 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.579 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 17' ' ' LEU . 38.9 t -60.19 -47.63 91.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.834 0.349 . . . . 0.0 110.285 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.532 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -56.51 -53.98 51.14 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.205 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.476 ' O ' HG13 ' A' ' 27' ' ' ILE . 19.5 pt20 -63.22 -40.46 97.53 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.256 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.54 -49.53 74.96 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 120.819 0.342 . . . . 0.0 110.427 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.43 -35.51 77.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.816 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.422 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 19.2 t -72.19 -54.47 9.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.079 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.476 HG13 ' O ' ' A' ' 23' ' ' GLN . 90.8 mt -55.0 -49.07 74.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.726 -178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.6 p -58.88 -50.59 73.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.02 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.8 m -60.7 -34.89 75.05 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.242 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 98.5 m -67.34 -49.49 63.83 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 120.79 0.329 . . . . 0.0 110.745 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -56.12 -40.99 74.6 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -60.38 -34.81 74.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 177.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.82 24.22 5.6 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 120.768 0.318 . . . . 0.0 111.741 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.2 32.77 2.81 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.996 175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 97.9 m -107.05 137.12 45.72 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.264 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.79 -40.55 96.83 Favored Glycine 0 CA--C 1.507 -0.452 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.917 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.1 t -156.58 175.33 14.18 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-O 121.006 0.432 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.27 150.61 22.89 Favored Glycine 0 N--CA 1.435 -1.367 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.845 -179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -149.96 152.74 35.44 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.532 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.4 m -85.24 121.21 27.65 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.234 0.54 . . . . 0.0 110.813 -178.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -124.26 136.85 54.45 Favored 'General case' 0 N--CA 1.43 -1.456 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.08 -178.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 5.7 mtp180 -87.67 113.05 22.98 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.161 0.505 . . . . 0.0 109.989 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.451 HH11 ' HD3' ' A' ' 43' ' ' ARG . 2.9 mmp_? -111.18 116.27 30.79 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.233 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.89 50.34 68.64 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.541 178.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.82 20.7 57.49 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.364 -178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -133.58 120.46 15.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.981 0.391 . . . . 0.0 110.639 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.71 116.74 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.66 2.24 . . . . 0.0 111.612 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -128.8 155.33 45.34 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.692 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 9.5 t -92.37 116.64 29.15 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.7 m -116.24 128.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 CA-C-O 121.456 0.646 . . . . 0.0 110.503 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 56.2 m -91.87 151.57 20.49 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.056 -178.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.3 m -130.28 153.96 48.11 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.92 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? 58.68 54.74 5.13 Favored 'General case' 0 C--N 1.331 -0.238 0 O-C-N 123.671 0.607 . . . . 0.0 110.776 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 76.2 m -89.59 -163.74 1.05 Allowed 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.57 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.82 71.68 0.7 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.104 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -90.73 157.67 17.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -146.61 -169.92 14.7 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.53 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -75.03 99.76 1.18 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.269 -0.491 . . . . 0.0 111.971 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.5 100.44 0.34 Allowed Glycine 0 N--CA 1.44 -1.1 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -143.27 136.39 27.95 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.851 0.358 . . . . 0.0 110.636 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -154.38 80.03 4.81 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.96 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.03 -43.3 0.4 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.681 2.254 . . . . 0.0 112.237 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -89.86 -26.22 20.61 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.474 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 22.9 mt 71.78 86.58 0.11 Allowed Pre-proline 0 N--CA 1.47 0.549 0 O-C-N 123.704 0.627 . . . . 0.0 109.749 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.53 2.91 6.86 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.946 2.43 . . . . 0.0 113.258 -177.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.8 t -80.55 103.51 10.45 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.065 0.46 . . . . 0.0 109.826 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.7 1.25 53.36 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.456 0.646 . . . . 0.0 109.969 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.436 0 CA-C-O 118.294 -1.281 . . . . 0.0 110.27 -176.171 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.7 m 58.3 45.45 17.06 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.124 0.487 . . . . 0.0 110.327 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.43 169.62 8.83 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.511 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.434 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -76.4 -21.46 55.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.825 178.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -137.45 150.41 47.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.989 0.424 . . . . 0.0 110.768 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -104.46 -25.86 12.63 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.442 0.639 . . . . 0.0 109.59 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.5 p -123.94 146.01 48.76 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.374 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -56.54 -26.9 56.23 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.296 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.9 m -101.29 13.1 36.16 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.98 70.67 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-O 121.167 0.508 . . . . 0.0 110.409 177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -10.9 19.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.361 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.56 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 11.3 ptp -57.91 -13.0 3.68 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.757 0.313 . . . . 0.0 110.809 177.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -106.17 22.27 15.99 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-O 121.053 0.454 . . . . 0.0 109.846 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.601 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.8 t70 -113.45 21.9 14.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.752 0.787 . . . . 0.0 109.694 -177.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.55 -172.88 39.77 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.389 -178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.28 73.46 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.883 0.373 . . . . 0.0 111.628 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.97 -44.64 84.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.16 -43.36 98.46 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.154 177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.76 72.06 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.17 0.51 . . . . 0.0 110.394 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.96 -46.16 72.18 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.714 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.0 t -62.07 -46.97 95.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.351 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.44 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -57.91 -54.0 51.87 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.508 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.441 ' O ' HG13 ' A' ' 27' ' ' ILE . 14.8 pt20 -61.43 -41.4 97.12 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.976 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.11 -48.91 74.26 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-O 120.865 0.365 . . . . 0.0 110.751 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.02 -35.93 80.03 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.432 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -69.47 -52.67 24.49 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.022 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -54.35 -52.76 36.03 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.993 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.5 m -58.96 -46.49 87.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.458 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.7 m -62.03 -35.57 78.97 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.868 0.366 . . . . 0.0 110.898 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.7 m -65.96 -50.89 62.76 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.555 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HD2' HG22 ' A' ' 27' ' ' ILE . 20.2 mtpp -58.7 -39.8 81.82 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.348 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.83 -36.84 75.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.928 179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -95.16 19.61 10.32 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 120.778 0.323 . . . . 0.0 111.449 -178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 t30 69.43 49.72 0.57 Allowed 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.834 0.826 . . . . 0.0 111.056 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 99.5 m -120.65 132.92 55.36 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.244 174.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.05 -42.37 93.01 Favored Glycine 0 C--N 1.321 -0.304 0 CA-C-N 115.888 -0.596 . . . . 0.0 113.633 -176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.432 HG23 ' HB2' ' A' ' 52' ' ' SER . 5.9 t -154.45 169.83 22.83 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-O 120.878 0.371 . . . . 0.0 111.134 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -145.24 148.05 19.56 Favored Glycine 0 N--CA 1.432 -1.628 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.805 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -150.11 152.37 34.65 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.44 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 67.3 m -84.58 124.62 31.63 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 121.063 0.459 . . . . 0.0 110.23 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -133.23 141.68 48.17 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.398 -178.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -89.54 114.94 26.56 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-O 121.451 0.643 . . . . 0.0 109.614 177.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HA ' ' NE ' ' A' ' 43' ' ' ARG . 4.2 mmp_? -107.16 106.75 17.38 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.145 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.07 48.09 87.84 Favored Glycine 0 N--CA 1.443 -0.834 0 C-N-CA 120.363 -0.923 . . . . 0.0 110.996 -176.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 75.34 -10.89 9.97 Favored Glycine 0 C--O 1.22 -0.772 0 C-N-CA 121.347 -0.454 . . . . 0.0 113.684 -177.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -95.78 108.38 39.96 Favored Pre-proline 0 C--N 1.311 -1.08 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -175.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.56 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 36.7 Cg_exo -61.56 106.02 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.681 2.254 . . . . 0.0 110.741 176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.4 m -124.13 155.87 37.67 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 12.4 t -89.54 103.59 16.21 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.6 m -102.49 125.6 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 CA-C-O 121.404 0.621 . . . . 0.0 110.204 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 m -96.38 151.68 19.31 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.277 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 37' ' ' THR . 11.6 m -122.51 150.39 42.62 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.273 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.5 mmp_? 59.63 54.15 4.64 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.402 0.62 . . . . 0.0 111.001 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.2 m -92.34 165.58 13.01 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.517 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.41 23.01 4.91 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -159.44 166.42 31.03 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -177.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 108.42 -57.21 0.44 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.44 -13.01 6.26 Favored Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.126 -1.035 . . . . 0.0 113.325 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 78.34 -37.91 1.81 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.807 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -163.36 -22.36 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.611 1.164 . . . . 0.0 110.27 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -74.73 120.6 82.35 Favored Pre-proline 0 CA--C 1.514 -0.424 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.749 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' O ' ' HB3' ' A' ' 63' ' ' ASN . 60.3 Cg_endo -74.15 96.72 0.96 Allowed 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.829 2.353 . . . . 0.0 112.093 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 10.4 t30 76.99 1.73 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.342 175.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.9 mt 70.76 85.85 0.12 Allowed Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.455 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -73.01 170.76 19.02 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 122.553 2.168 . . . . 0.0 110.334 174.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.6 m -85.31 159.79 19.96 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 121.073 -0.251 . . . . 0.0 110.458 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -81.39 -20.77 39.78 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.575 0 CA-C-O 118.627 -1.096 . . . . 0.0 111.225 179.552 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.189 0 N-CA-C 111.849 -0.501 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 p -82.75 51.56 1.92 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.976 0.417 . . . . 0.0 111.383 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.44 147.6 38.18 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.791 0.329 . . . . 0.0 110.756 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -77.51 -24.4 50.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.35 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.26 146.3 34.97 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.688 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -106.77 -15.63 14.69 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.412 0.625 . . . . 0.0 110.088 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.552 HG23 ' HB2' ' A' ' 10' ' ' ALA . 0.1 OUTLIER -114.72 144.46 43.42 Favored 'General case' 0 N--CA 1.436 -1.13 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.362 -178.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.5 m -71.24 -17.88 62.48 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.975 -176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 63.8 m -104.65 14.91 28.99 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' HG23 ' A' ' 7' ' ' THR . . . -62.63 -32.1 73.07 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.449 0.642 . . . . 0.0 110.647 177.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.575 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -66.8 -9.26 35.31 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.064 -179.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.529 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 9.7 ptp -55.56 -18.42 7.44 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -116.02 25.62 10.56 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-O 121.362 0.601 . . . . 0.0 110.229 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 26.9 t70 -102.88 17.32 24.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.58 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 104.11 173.95 25.36 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -54.6 -38.31 66.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.873 0.337 . . . . 0.0 111.6 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -64.74 -42.86 94.88 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.75 -44.44 95.82 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.988 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.06 -40.06 76.12 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.777 0.323 . . . . 0.0 111.191 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -67.62 -40.92 84.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.531 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 17' ' ' LEU . 52.2 t -63.16 -44.34 99.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.034 0.445 . . . . 0.0 110.09 176.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.52 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -56.8 -55.04 39.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.7 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.467 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -60.54 -41.7 95.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.973 -178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.63 -48.4 74.98 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-O 120.738 0.304 . . . . 0.0 110.743 -179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.42 77.55 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.599 178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 35.3 t -71.24 -51.37 25.0 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.762 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 23' ' ' GLN . 92.1 mt -55.83 -51.42 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.8 -179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 13.3 p -58.95 -48.06 82.86 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.075 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.2 t -59.07 -39.53 82.41 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.629 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.502 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -65.65 -48.07 73.4 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.635 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -57.8 -41.41 82.07 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.097 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -61.2 -33.98 74.35 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -94.47 24.19 4.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.946 0.403 . . . . 0.0 111.492 -178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.13 31.71 2.41 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.614 174.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 88.0 m -107.45 134.87 49.86 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.131 176.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -63.35 -35.92 92.71 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.135 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 t -151.87 163.73 38.61 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 120.95 0.405 . . . . 0.0 111.197 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.502 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.64 144.93 14.27 Favored Glycine 0 N--CA 1.433 -1.547 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.684 -178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -150.51 153.56 36.04 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.924 0.393 . . . . 0.0 110.069 178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.439 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 68.6 m -86.44 126.69 34.58 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.715 -179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.64 140.84 48.37 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 20.4 mtp180 -89.93 113.39 25.01 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.282 0.563 . . . . 0.0 111.177 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 34.0 mmt180 -107.19 104.77 14.49 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.778 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.63 53.38 46.57 Favored Glycine 0 C--O 1.227 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.405 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.03 -12.52 6.5 Favored Glycine 0 C--O 1.23 -0.112 0 C-N-CA 121.529 -0.367 . . . . 0.0 113.461 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -96.67 112.33 59.94 Favored Pre-proline 0 C--N 1.31 -1.136 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.529 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 38.3 Cg_endo -67.97 108.06 1.64 Allowed 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.441 2.094 . . . . 0.0 110.709 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.6 m -120.26 154.94 34.21 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 120.81 -0.356 . . . . 0.0 111.091 -176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.5 t -90.72 104.26 16.87 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 176.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.5 m -104.42 125.05 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.167 0 CA-C-O 121.544 0.688 . . . . 0.0 109.852 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 30.2 m -95.61 157.98 15.65 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.493 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 17.4 m -136.89 161.6 35.57 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.552 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.1 mmp_? 62.99 39.87 9.82 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.327 0.584 . . . . 0.0 110.119 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.535 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 61.2 m -89.48 -170.76 2.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.2 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.54 49.94 3.13 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.655 -0.783 . . . . 0.0 111.734 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -115.47 -4.49 12.3 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.072 0.463 . . . . 0.0 110.582 -178.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 88.76 -66.65 3.1 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.288 178.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 153.88 -169.83 32.49 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.245 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.93 70.33 1.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.398 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -142.49 145.73 34.0 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.081 0.467 . . . . 0.0 110.778 -176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -125.06 107.1 28.24 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.933 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.65 -34.85 49.88 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.21 1.94 . . . . 0.0 111.512 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.53 -19.85 22.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.38 179.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.4 mt 54.57 86.52 0.16 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 123.36 0.413 . . . . 0.0 111.479 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -74.94 68.39 5.72 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 122.511 2.14 . . . . 0.0 112.794 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.0 p -72.81 -35.54 67.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.097 0.475 . . . . 0.0 110.526 177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.5 OUTLIER -93.64 133.26 37.16 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.225 177.147 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.942 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.35 -178.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.309 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.3 t -80.24 74.5 7.06 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.12 0.486 . . . . 0.0 110.222 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.55 139.6 20.11 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.442 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.742 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.0 pt? -83.39 -35.35 25.15 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.453 177.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -90.12 118.18 29.46 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.843 -178.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.427 ' CD2' HG23 ' A' ' 7' ' ' THR . 11.4 p90 -99.91 -26.65 13.93 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 173.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.427 HG23 ' CD2' ' A' ' 6' ' ' PHE . 19.5 p -123.87 168.25 13.02 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.505 174.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.0 m -78.76 -18.42 54.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.196 0.522 . . . . 0.0 110.895 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 81.6 m -102.76 14.56 31.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.47 -31.65 70.65 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.63 0.729 . . . . 0.0 110.6 177.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.66 -10.43 36.17 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.013 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.535 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 10.8 ptp -54.59 -20.42 7.95 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -112.8 26.84 10.15 Favored 'General case' 0 CA--C 1.522 -0.108 0 C-N-CA 120.239 -0.584 . . . . 0.0 110.598 -179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 12.1 t70 -104.09 22.34 14.85 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.52 174.98 32.59 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.694 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -55.94 -36.57 67.92 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.555 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -67.88 -43.35 79.55 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.08 -37.9 87.51 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.722 178.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.59 -44.32 80.94 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.264 0.555 . . . . 0.0 111.163 178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 23' ' ' GLN . 37.5 mttt -70.12 -39.9 75.2 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.574 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 17' ' ' LEU . 34.2 t -60.78 -44.7 98.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 176.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.69 -53.88 53.22 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.298 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.542 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.67 -40.4 94.81 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.971 -178.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.05 76.75 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.941 0.4 . . . . 0.0 110.63 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.63 77.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.559 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 42.7 t -71.35 -54.2 11.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.911 -178.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 23' ' ' GLN . 85.3 mt -55.05 -50.04 66.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.831 -178.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 5.9 m -59.01 -48.05 83.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.08 -178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -62.34 -35.26 78.54 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.813 0.34 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 87.7 m -66.38 -47.63 72.74 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 120.9 0.381 . . . . 0.0 110.694 179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.511 ' HD2' HG22 ' A' ' 27' ' ' ILE . 3.9 mtpm? -55.43 -40.06 71.04 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.125 178.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -62.05 -32.39 72.9 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -98.19 24.15 7.48 Favored 'General case' 0 C--O 1.241 0.641 0 CA-C-O 120.668 0.27 . . . . 0.0 111.428 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 65.5 t30 71.75 42.19 0.65 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.525 176.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 92.9 m -117.8 135.55 53.99 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.093 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.93 -40.78 93.72 Favored Glycine 0 CA--C 1.508 -0.35 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.574 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -156.98 -179.28 8.06 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 120.956 0.408 . . . . 0.0 110.644 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -148.85 151.53 23.69 Favored Glycine 0 N--CA 1.432 -1.597 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.467 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -148.13 146.35 28.74 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.998 0.428 . . . . 0.0 109.92 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 79.7 m -82.68 125.74 31.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' HG2' ' CZ ' ' A' ' 43' ' ' ARG . 5.5 tp10 -130.02 139.43 51.02 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.377 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.535 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 15.5 mtp180 -91.7 113.21 25.42 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.279 0.561 . . . . 0.0 110.302 177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' CZ ' ' HG2' ' A' ' 41' ' ' GLU . 34.2 mmt180 -105.5 104.02 13.66 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.735 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 57.27 51.82 55.25 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.063 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' HA2' HH21 ' A' ' 42' ' ' ARG . . . 79.38 -16.36 10.2 Favored Glycine 0 C--O 1.227 -0.304 0 C-N-CA 121.358 -0.449 . . . . 0.0 113.647 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 25.0 mmt180 -89.3 111.97 48.56 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -176.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 42.8 Cg_endo -69.09 110.36 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.097 1.865 . . . . 0.0 110.33 176.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -128.93 155.3 45.53 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-O 121.031 0.443 . . . . 0.0 111.292 -174.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 17.3 t -92.44 109.77 21.17 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.15 125.97 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.085 0 CA-C-O 121.389 0.614 . . . . 0.0 109.717 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.437 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 39.4 m -87.25 150.17 24.08 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.049 -175.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -125.49 152.57 44.78 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.578 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? 61.22 49.13 5.68 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.281 0.562 . . . . 0.0 110.379 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.579 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 73.4 m -90.19 156.38 18.36 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.048 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -107.82 28.45 12.24 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 -100.41 76.95 1.89 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.637 -0.781 . . . . 0.0 109.356 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.62 119.92 5.0 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.818 -177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.09 -68.13 0.24 Allowed Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.258 178.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -119.32 134.67 10.84 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.434 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -157.25 143.63 17.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.239 0.543 . . . . 0.0 110.504 178.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 23.2 p90 -155.73 89.8 2.88 Favored Pre-proline 0 C--N 1.308 -1.212 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.793 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.83 -39.14 0.3 Allowed 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.662 2.241 . . . . 0.0 113.52 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -81.11 -17.61 49.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.162 -178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 67.5 mt 66.79 93.74 0.06 OUTLIER Pre-proline 0 N--CA 1.466 0.369 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.824 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -66.87 -18.61 52.68 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.532 2.155 . . . . 0.0 111.788 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.6 p -160.55 149.9 17.29 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.845 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.99 146.89 31.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.708 0.289 . . . . 0.0 110.617 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.189 0 CA-C-O 118.991 -0.894 . . . . 0.0 111.146 178.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.6 t -126.66 37.63 4.26 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.337 0.589 . . . . 0.0 110.032 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.12 142.69 44.29 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.576 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.636 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.2 pt? -77.81 -47.85 17.91 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.105 0.479 . . . . 0.0 110.004 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.498 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 20.9 m-20 -91.75 95.52 9.92 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.448 ' CD2' HG23 ' A' ' 7' ' ' THR . 11.7 p90 -95.48 -17.83 21.16 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.448 HG23 ' CD2' ' A' ' 6' ' ' PHE . 9.4 p -124.53 160.43 28.38 Favored 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.997 178.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -68.02 -20.9 65.04 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.157 0.503 . . . . 0.0 109.827 177.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.565 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.7 m -104.11 10.34 35.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -178.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.97 -32.69 71.06 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.336 0.589 . . . . 0.0 110.826 178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -63.77 -10.21 18.65 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.273 179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.3 ptp -55.75 -18.49 8.44 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 122.347 -0.221 . . . . 0.0 111.381 178.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -113.62 25.73 11.0 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-O 121.306 0.574 . . . . 0.0 110.411 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -101.15 23.47 10.79 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.684 0.754 . . . . 0.0 108.966 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 101.4 171.62 28.23 Favored Glycine 0 N--CA 1.436 -1.32 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -175.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.9 -38.12 55.05 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.77 -35.82 80.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.02 87.81 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.022 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.13 -40.02 76.3 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 120.744 0.307 . . . . 0.0 111.37 178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -71.16 -41.21 70.69 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.959 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -62.92 -45.19 99.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.397 0.618 . . . . 0.0 109.55 177.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.0 -52.56 64.8 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.653 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.518 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.6 pt20 -62.73 -39.33 93.76 Favored 'General case' 0 C--O 1.221 -0.424 0 O-C-N 123.224 0.328 . . . . 0.0 110.717 -177.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.54 -48.15 76.15 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.244 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.16 74.88 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.421 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 47.5 t -67.98 -48.46 65.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.344 179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.518 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.0 mt -56.83 -48.9 80.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.603 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.9 p -60.58 -46.33 90.63 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.795 179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.8 m -58.76 -36.94 75.18 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 121.017 0.437 . . . . 0.0 110.743 179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.1 m -68.88 -48.78 62.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.74 179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -61.28 -36.17 79.32 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.363 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -58.96 -37.86 77.73 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 175.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -93.74 17.8 11.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.774 0.321 . . . . 0.0 111.324 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.5 t30 69.02 49.37 0.64 Allowed 'General case' 0 C--O 1.239 0.553 0 CA-C-O 121.606 0.717 . . . . 0.0 111.042 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 98.2 m -123.41 130.71 53.09 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.223 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.47 -29.38 73.27 Favored Glycine 0 C--N 1.316 -0.565 0 CA-C-N 115.463 -0.789 . . . . 0.0 114.319 -174.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.1 t -155.6 166.77 32.51 Favored 'General case' 0 N--CA 1.43 -1.461 0 C-N-CA 120.078 -0.649 . . . . 0.0 111.39 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.51 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -146.93 148.76 20.66 Favored Glycine 0 N--CA 1.429 -1.793 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.852 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 20.9 p-80 -149.71 149.71 31.0 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 61.3 m -84.79 125.4 32.54 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.922 -177.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -138.54 143.83 39.63 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.618 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 26.7 mtp180 -91.78 126.36 36.84 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.276 0.56 . . . . 0.0 111.051 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -118.7 112.11 19.36 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.25 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.45 44.32 95.38 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.88 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.33 -8.09 34.63 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.599 -178.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 37.0 mmt180 -92.4 113.55 59.68 Favored Pre-proline 0 C--N 1.317 -0.821 0 CA-C-N 116.702 0.251 . . . . 0.0 111.371 -177.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.471 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 48.4 Cg_endo -69.42 100.32 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.207 1.938 . . . . 0.0 111.069 175.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 62.6 m -120.09 156.9 30.07 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.995 -175.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.2 t -91.42 107.37 19.16 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.8 m -104.43 123.53 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 CA-C-O 121.505 0.669 . . . . 0.0 109.999 -179.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 33.7 m -94.52 159.36 15.13 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.584 -0.735 . . . . 0.0 112.399 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -137.59 162.56 33.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.103 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 53' ' ' ARG . 10.4 mmt180 64.67 42.92 4.47 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 123.429 0.456 . . . . 0.0 110.547 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 78.7 m -83.79 135.86 34.37 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.31 26.62 69.89 Favored Glycine 0 N--CA 1.447 -0.575 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 -171.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -155.25 170.61 21.46 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.327 -0.937 . . . . 0.0 110.196 -174.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -88.89 -176.13 46.71 Favored Glycine 0 N--CA 1.439 -1.151 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 176.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -161.8 -122.65 0.63 Allowed Glycine 0 CA--C 1.5 -0.885 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -56.79 -44.08 91.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.636 -0.792 . . . . 0.0 111.333 176.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -162.91 165.55 24.99 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.797 0.332 . . . . 0.0 110.372 176.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -79.12 126.07 82.46 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.767 176.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.36 87.51 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.759 2.306 . . . . 0.0 111.907 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.7 t30 70.5 3.71 4.62 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.545 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mp 65.04 93.56 0.06 OUTLIER Pre-proline 0 C--O 1.232 0.143 0 CA-C-O 121.055 0.455 . . . . 0.0 111.12 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.76 -171.57 1.0 Allowed 'Trans proline' 0 C--O 1.237 0.472 0 C-N-CA 122.637 2.224 . . . . 0.0 112.284 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.9 p -82.13 130.02 34.98 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.614 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -91.22 -23.61 20.14 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.44 0.638 . . . . 0.0 109.749 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -2.144 0 CA-C-O 118.061 -1.411 . . . . 0.0 110.862 -179.46 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.195 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.1 p 49.37 27.17 1.85 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.801 0.84 . . . . 0.0 112.832 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -167.3 162.72 15.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.588 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.508 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.7 pt? -74.95 -26.4 59.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.568 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -141.91 151.71 42.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.416 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 p90 -99.54 -21.38 15.94 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -124.05 145.52 49.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.941 0.4 . . . . 0.0 111.934 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.6 m -66.32 -23.16 66.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.006 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 20.5 m -94.22 6.94 47.07 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.4 -21.53 65.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.033 0.444 . . . . 0.0 110.273 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -63.18 -16.51 60.36 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.117 179.455 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.544 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 13.4 ptp -56.24 -18.58 10.84 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 120.634 0.254 . . . . 0.0 111.373 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.6 p30 -117.88 23.92 11.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 121.339 0.59 . . . . 0.0 109.843 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.443 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.3 t70 -101.36 14.76 30.97 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.71 170.48 23.56 Favored Glycine 0 N--CA 1.438 -1.223 0 N-CA-C 110.711 -0.955 . . . . 0.0 110.711 -175.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.77 -34.06 62.15 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 178.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -67.99 -40.54 83.05 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 11' ' ' ARG . . . -58.2 -39.68 92.7 Favored Glycine 0 N--CA 1.443 -0.855 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.272 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.05 -43.72 70.47 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.858 0.361 . . . . 0.0 111.155 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.59 -39.47 80.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.33 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 17' ' ' LEU . 24.9 t -62.78 -48.63 87.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 0.0 110.159 177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.43 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -55.88 -52.15 65.07 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.676 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.9 pt20 -61.88 -40.93 97.11 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.969 -177.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.16 81.99 Favored 'General case' 0 C--O 1.24 0.571 0 CA-C-O 121.016 0.436 . . . . 0.0 110.733 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.19 -37.14 84.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.437 178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 22.6 t -68.83 -50.58 48.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.918 -179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 87.9 mt -55.51 -53.67 33.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 CA-C-N 116.624 -0.262 . . . . 0.0 110.938 -178.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.9 p -58.09 -46.86 84.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.636 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.2 m -61.96 -36.63 82.01 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 120.826 0.346 . . . . 0.0 110.816 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.406 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 82.4 m -66.43 -46.82 75.21 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-O 121.259 0.552 . . . . 0.0 110.516 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' HD2' HG22 ' A' ' 27' ' ' ILE . 51.5 mtpt -59.21 -37.73 78.18 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.51 178.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -61.41 -32.58 72.53 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -94.87 19.66 9.89 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.095 0.474 . . . . 0.0 110.813 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 70.21 36.72 1.78 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.593 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 94.6 m -106.58 135.61 47.81 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.153 176.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -59.11 -40.28 95.44 Favored Glycine 0 CA--C 1.509 -0.299 0 CA-C-N 115.64 -0.709 . . . . 0.0 113.218 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -153.6 169.58 22.91 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.184 0.516 . . . . 0.0 111.083 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 145.77 15.55 Favored Glycine 0 N--CA 1.425 -2.068 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.991 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 19.4 p-80 -148.96 147.76 28.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 120.915 0.388 . . . . 0.0 109.999 179.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.43 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 65.9 m -84.32 126.37 33.13 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.826 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -135.3 141.31 45.64 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.731 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 7.3 mtp180 -92.56 124.91 36.93 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-O 121.08 0.467 . . . . 0.0 109.87 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -129.67 119.52 23.67 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.823 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 56.05 42.89 88.1 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.985 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA2' ' NH2' ' A' ' 42' ' ' ARG . . . 76.03 -10.52 14.42 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 121.444 -0.408 . . . . 0.0 113.581 -178.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.406 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 4.2 mmp_? -92.0 114.3 61.67 Favored Pre-proline 0 C--N 1.31 -1.113 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.525 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 9.4 Cg_exo -71.74 105.84 1.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.349 2.033 . . . . 0.0 109.842 175.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.8 m -122.32 155.27 36.33 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.224 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.3 t -92.22 109.69 21.06 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.5 m -109.74 127.74 66.34 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.83 0 CA-C-O 121.419 0.628 . . . . 0.0 110.959 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.8 m -93.53 148.61 21.93 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.532 -177.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.5 m -126.69 151.85 47.56 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.535 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.537 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.6 mmp_? 61.19 52.7 3.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.347 0.594 . . . . 0.0 111.246 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.2 m -90.75 158.05 17.08 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.507 178.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.58 -55.83 11.09 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.213 -0.994 . . . . 0.0 111.096 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 57.82 78.1 0.25 Allowed 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.405 0.622 . . . . 0.0 110.542 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -164.68 60.14 0.25 Allowed Glycine 0 N--CA 1.438 -1.212 0 N-CA-C 110.534 -1.026 . . . . 0.0 110.534 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.68 84.05 1.0 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.232 -177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.7 171.36 38.11 Favored Glycine 0 N--CA 1.436 -1.354 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.031 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -84.62 -32.28 23.8 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.227 0.537 . . . . 0.0 109.888 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -127.48 93.19 41.3 Favored Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.654 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.53 -35.03 6.65 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.394 2.063 . . . . 0.0 112.659 -179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -90.51 -24.46 20.64 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.721 0.267 . . . . 0.0 111.721 -179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 95.7 mt 70.27 86.93 0.11 Allowed Pre-proline 0 N--CA 1.472 0.648 0 C-N-CA 123.007 0.523 . . . . 0.0 111.525 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -88.93 65.21 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.896 2.397 . . . . 0.0 111.294 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 51.9 m -157.54 157.37 33.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.122 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -84.56 -61.1 1.88 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.056 0.455 . . . . 0.0 110.426 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.62 0 CA-C-O 118.054 -1.414 . . . . 0.0 110.722 -178.488 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.052 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.2 m -102.68 93.86 5.32 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.014 0.435 . . . . 0.0 111.166 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -120.52 132.25 55.09 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.609 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -77.24 -42.98 35.16 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -143.42 149.35 37.51 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.834 0.349 . . . . 0.0 110.718 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.48 ' CD2' HG23 ' A' ' 7' ' ' THR . 12.4 p90 -108.62 -31.38 7.78 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.287 0.565 . . . . 0.0 110.248 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.48 HG23 ' CD2' ' A' ' 6' ' ' PHE . 11.6 p -122.24 152.34 40.12 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.381 178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.7 m -62.05 -19.32 62.79 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.644 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.657 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 70.5 m -106.65 12.31 29.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 -174.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -35.96 77.3 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.527 0.679 . . . . 0.0 110.588 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.555 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.8 -7.88 12.85 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.669 -0.696 . . . . 0.0 112.853 -179.71 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.592 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.6 ptp -54.04 -17.35 2.57 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.607 0.241 . . . . 0.0 111.018 177.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -122.18 25.39 9.02 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-O 121.13 0.49 . . . . 0.0 110.176 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.453 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 38.8 t70 -89.97 0.89 56.84 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.572 0.701 . . . . 0.0 109.758 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 127.07 -162.38 21.17 Favored Glycine 0 N--CA 1.433 -1.553 0 N-CA-C 110.824 -0.911 . . . . 0.0 110.824 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -70.94 -46.74 61.89 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.609 0.719 . . . . 0.0 109.601 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -65.28 -29.47 70.24 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.055 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -61.35 -40.68 98.97 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.616 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.59 -39.23 79.8 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.936 0.398 . . . . 0.0 111.61 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -37.52 71.43 Favored 'General case' 0 CA--C 1.511 -0.54 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.685 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.4 t -66.36 -42.84 91.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.423 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.42 -54.69 44.15 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.512 -179.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.439 ' O ' HG13 ' A' ' 27' ' ' ILE . 15.5 pt20 -62.66 -40.38 96.86 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.704 -178.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.65 -47.81 77.12 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.923 0.392 . . . . 0.0 110.607 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.59 91.77 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.214 178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.657 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 43.5 t -64.88 -52.64 55.46 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.343 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG22 ' HD2' ' A' ' 31' ' ' LYS . 94.6 mt -56.42 -48.06 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.709 -179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 32' ' ' PHE . 16.9 m -59.68 -49.87 76.05 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.962 179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.6 p -60.31 -33.67 72.7 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 120.726 0.298 . . . . 0.0 111.102 -179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 94.8 m -66.87 -48.37 69.01 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.048 177.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.44 ' HD2' HG22 ' A' ' 27' ' ' ILE . 21.4 mtpp -59.93 -41.31 91.5 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.04 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.402 ' HD1' ' O ' ' A' ' 28' ' ' SER . 9.7 m-85 -59.25 -37.0 76.5 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 177.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -93.1 19.46 7.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 0.0 111.568 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.9 t30 70.16 42.42 0.97 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.725 0.774 . . . . 0.0 111.626 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.4 m -113.37 137.36 51.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.793 176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.3 -42.36 88.61 Favored Glycine 0 C--N 1.324 -0.133 0 CA-C-N 115.951 -0.568 . . . . 0.0 113.346 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.7 t -157.6 177.22 11.64 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 120.744 0.307 . . . . 0.0 111.207 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -149.96 151.79 23.81 Favored Glycine 0 N--CA 1.437 -1.271 0 CA-C-N 115.615 -0.72 . . . . 0.0 112.228 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -149.54 151.22 33.52 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.443 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.0 m -85.07 122.87 29.91 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.03 0.443 . . . . 0.0 111.487 -177.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -132.98 136.17 45.91 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 -85.65 124.73 32.51 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.418 0.628 . . . . 0.0 110.868 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -108.73 104.91 14.28 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.745 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.33 50.22 60.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.843 -177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.527 ' O ' ' HD3' ' A' ' 47' ' ' PRO . . . 80.84 -19.05 7.93 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 121.008 -0.615 . . . . 0.0 113.634 -178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.8 mmt180 -88.65 108.9 25.7 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.97 0.385 . . . . 0.0 111.925 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.592 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.4 Cg_exo -60.16 97.3 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.75 2.3 . . . . 0.0 111.666 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.9 m -108.61 155.81 20.25 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.162 0.506 . . . . 0.0 111.192 -176.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 13.7 t -95.09 108.3 20.39 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.9 m -103.01 123.04 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 CA-C-O 121.535 0.683 . . . . 0.0 110.13 -178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 36.1 m -95.97 155.26 16.83 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.099 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.3 m -128.67 153.56 47.18 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.269 178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 1.5 mmp_? 62.72 48.68 4.1 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.553 0.533 . . . . 0.0 110.652 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 80.7 m -91.53 -179.13 5.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.979 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.74 109.94 3.15 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.283 -0.961 . . . . 0.0 111.862 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -153.2 148.56 27.03 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -79.95 104.8 2.25 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 120.258 -0.972 . . . . 0.0 111.9 179.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.23 -84.6 0.22 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.219 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 83.52 -76.6 2.22 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.685 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -159.73 -175.55 5.21 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 65' ' ' PRO . 82.3 m95 -136.89 130.19 17.53 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.9 -46.52 28.67 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.835 2.357 . . . . 0.0 113.277 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -137.27 24.52 2.97 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.446 -177.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 52.4 mt 54.2 89.91 0.1 OUTLIER Pre-proline 0 N--CA 1.474 0.765 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.117 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 94.7 Cg_endo -78.55 60.45 7.59 Favored 'Trans proline' 0 C--O 1.238 0.484 0 C-N-CA 122.722 2.281 . . . . 0.0 112.043 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 23.1 t -83.38 157.79 22.38 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.433 ' C ' ' HD3' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -85.21 -41.81 15.28 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 177.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.346 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.629 178.237 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.953 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.1 m -96.74 92.66 6.29 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 120.835 0.35 . . . . 0.0 110.188 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -157.5 140.18 14.89 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.822 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.647 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.0 pt? -82.84 -44.81 15.04 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.782 178.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.408 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 32.8 m-20 -98.01 123.4 42.0 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.743 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.4 p90 -101.65 -20.72 14.9 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.33 0.586 . . . . 0.0 110.256 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 p -123.4 158.59 30.79 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.307 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -63.66 -26.97 68.91 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.28 0.562 . . . . 0.0 110.727 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 68.3 m -104.8 16.75 25.4 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.78 -31.75 72.78 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.181 0.515 . . . . 0.0 110.55 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.23 -9.81 19.54 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.294 178.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.0 ptp -57.54 -12.59 2.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-O 120.681 0.277 . . . . 0.0 110.389 176.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 47' ' ' PRO . 39.1 m-80 -103.09 18.94 20.51 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-O 120.997 0.427 . . . . 0.0 109.887 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.532 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 23.4 t70 -112.68 26.54 10.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.718 0.77 . . . . 0.0 109.322 -177.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.38 -173.93 39.47 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.244 -179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.27 -33.78 74.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.794 0.33 . . . . 0.0 111.107 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.478 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -67.58 -42.98 81.67 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.532 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.68 -42.22 97.78 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.517 177.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -36.8 75.23 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.128 0.49 . . . . 0.0 110.309 177.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.16 -45.44 73.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 17' ' ' LEU . 47.6 t -63.09 -44.95 99.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.958 -0.564 . . . . 0.0 109.948 177.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.91 -52.71 64.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.624 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.8 pt20 -60.97 -40.48 93.56 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.857 -178.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.19 -45.63 90.85 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 121.061 0.458 . . . . 0.0 110.345 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.72 -36.98 85.64 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.357 178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.526 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 49.4 t -69.32 -54.06 16.48 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.741 -177.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.577 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 70.8 mt -54.86 -49.61 68.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.432 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.247 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.449 ' HA ' ' HD3' ' A' ' 31' ' ' LYS . 14.9 m -59.76 -45.27 92.76 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.662 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 85.0 p -61.93 -34.51 76.22 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.177 0.513 . . . . 0.0 110.67 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 91.1 m -67.1 -46.21 74.89 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.474 179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.5 mtpm? -56.5 -41.35 76.51 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.8 178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -59.38 -33.63 71.44 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.5 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.9 pt20 -96.7 16.39 19.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.96 0.41 . . . . 0.0 111.094 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.4 t30 68.26 49.46 0.82 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.039 178.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 87.5 m -115.74 136.5 53.0 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.452 175.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -61.47 -38.6 96.04 Favored Glycine 0 C--N 1.315 -0.623 0 CA-C-N 115.722 -0.672 . . . . 0.0 113.146 -177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.2 t -154.89 165.63 36.07 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.506 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.516 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -143.13 147.7 19.18 Favored Glycine 0 N--CA 1.435 -1.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.706 179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 17.8 p-80 -149.43 151.4 33.96 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.417 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 60.4 m -83.59 123.15 29.48 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.169 0.509 . . . . 0.0 110.45 -179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -132.73 140.95 48.31 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 -89.74 123.71 33.99 Favored 'General case' 0 CA--C 1.493 -1.229 0 CA-C-O 121.038 0.446 . . . . 0.0 109.983 178.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 43' ' ' ARG . 2.8 mmp_? -111.01 103.55 12.03 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.023 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.31 49.9 71.7 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.13 -176.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.38 -20.99 6.47 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.253 -0.498 . . . . 0.0 113.866 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HA ' ' HD2' ' A' ' 47' ' ' PRO . 92.3 mtt180 -86.32 113.04 50.23 Favored Pre-proline 0 C--N 1.315 -0.898 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -174.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 39.5 Cg_endo -65.84 105.48 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 122.588 2.192 . . . . 0.0 110.929 177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 m -124.64 156.36 37.63 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.004 0.431 . . . . 0.0 110.951 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.3 t -92.36 112.09 23.91 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.1 m -109.62 127.31 66.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.177 0 CA-C-O 121.31 0.576 . . . . 0.0 110.304 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 31.1 m -99.72 157.54 16.41 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.496 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.4 t -135.8 162.8 31.78 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-N 115.423 -0.808 . . . . 0.0 108.924 177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.647 ' HA ' ' CZ ' ' A' ' 53' ' ' ARG . 2.9 mmp_? 59.84 46.74 10.96 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.517 0.675 . . . . 0.0 110.56 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.8 m -92.97 163.32 13.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.261 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.03 35.02 4.14 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.474 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 28.8 p-10 -96.7 -153.77 0.42 Allowed 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -135.61 108.23 0.67 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.29 -142.17 17.4 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.231 -0.985 . . . . 0.0 111.934 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 111.56 36.04 1.8 Allowed Glycine 0 C--N 1.316 -0.573 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -80.99 -179.36 7.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.169 0.509 . . . . 0.0 111.401 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 22.0 m-90 -99.22 106.44 38.71 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.252 -179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.94 -56.72 0.07 OUTLIER 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.44 2.093 . . . . 0.0 112.994 -177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -83.54 -9.12 59.15 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.068 -177.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 62.5 mt 62.6 80.1 0.25 Allowed Pre-proline 0 C--O 1.237 0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.073 -177.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.86 165.01 27.09 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.543 2.162 . . . . 0.0 113.015 -177.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.9 t -86.1 -160.01 0.51 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.247 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -94.43 -65.88 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.79 0 CA-C-O 118.296 -1.28 . . . . 0.0 111.813 178.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.123 0 N-CA-C 112.016 -0.433 . . . . 0.0 112.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.9 m 64.96 18.87 11.69 Favored 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 122.977 0.511 . . . . 0.0 111.177 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.23 164.37 38.43 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.18 0.514 . . . . 0.0 111.743 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.7 pt? -74.47 -21.73 59.44 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.293 177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -141.11 151.41 43.92 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.757 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 49.8 p90 -111.76 -14.99 13.5 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.464 0.65 . . . . 0.0 109.885 177.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.1 131.63 54.07 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.284 -178.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 m -57.61 -18.46 20.07 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.574 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 60.0 m -99.23 9.49 43.3 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -178.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.76 -34.76 71.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.109 0.48 . . . . 0.0 111.318 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.577 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -65.7 -9.78 30.74 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.728 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.514 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 8.2 ptp -54.48 -21.63 10.52 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 111.552 0.204 . . . . 0.0 111.552 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -107.98 22.12 16.41 Favored 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 120.211 -0.595 . . . . 0.0 110.597 -177.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.457 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 33.5 t70 -101.35 26.89 6.7 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.34 -179.83 37.82 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.202 -177.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -37.07 73.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.627 0.251 . . . . 0.0 111.453 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -61.48 -45.7 93.15 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -58.93 -41.25 96.17 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.188 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.56 -39.97 74.37 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.776 0.322 . . . . 0.0 110.988 178.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.34 -42.39 75.35 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.703 179.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 17' ' ' LEU . 49.7 t -61.53 -46.06 97.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.331 0.586 . . . . 0.0 110.151 178.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.455 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -58.69 -54.78 43.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.647 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -60.6 -39.06 86.76 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.314 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.44 -47.99 81.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.008 0.432 . . . . 0.0 110.427 -179.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -64.03 -35.73 81.67 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.851 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.6 t -73.48 -54.71 7.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.187 -176.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 90.8 mt -53.49 -51.1 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.743 0.306 . . . . 0.0 110.807 -179.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.5 m -59.93 -45.46 92.54 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.531 -178.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.6 m -63.87 -34.76 78.67 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.935 0.398 . . . . 0.0 110.949 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.512 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 99.1 m -68.12 -47.91 66.85 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.756 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.7 mtpp -58.74 -37.37 76.05 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.293 0.568 . . . . 0.0 109.901 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -58.5 -38.5 77.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -95.83 23.4 6.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -176.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t30 70.13 38.72 1.44 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.792 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 96.2 m -109.73 135.92 49.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 53' ' ' ARG . . . -55.91 -42.15 85.76 Favored Glycine 0 C--N 1.315 -0.62 0 O-C-N 123.654 0.597 . . . . 0.0 112.764 -178.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.7 t -157.91 176.2 12.86 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.512 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -148.24 147.82 18.76 Favored Glycine 0 N--CA 1.426 -2.028 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -149.49 149.9 31.49 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.056 0.455 . . . . 0.0 109.796 178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 82.5 m -83.64 125.47 31.87 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -129.85 136.2 49.28 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.71 -177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.514 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 8.6 mtp180 -94.27 127.22 40.0 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-O 121.118 0.485 . . . . 0.0 110.187 -179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -132.14 122.6 25.6 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.646 -177.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.98 40.96 83.65 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.138 -0.554 . . . . 0.0 111.889 -175.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.74 -12.09 9.12 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.601 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 46' ' ' ARG . 3.1 mmp_? -92.13 120.3 67.82 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-O 120.803 0.335 . . . . 0.0 111.533 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 106.67 2.22 Favored 'Trans proline' 0 C--O 1.219 -0.468 0 C-N-CA 122.707 2.271 . . . . 0.0 111.913 177.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.5 m -115.39 151.41 34.74 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.724 0.297 . . . . 0.0 111.413 -175.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 14.8 t -92.68 106.18 18.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 175.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 m -110.6 129.93 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 CA-C-O 121.446 0.641 . . . . 0.0 110.942 -178.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 24.9 m -98.82 156.57 16.8 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.0 p -132.59 160.23 37.2 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.614 177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.427 ' HB2' ' HA3' ' A' ' 36' ' ' GLY . 14.5 mmt180 60.65 47.78 7.91 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 121.541 0.686 . . . . 0.0 109.565 -175.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . . . . . . . . . 69.6 m -101.55 136.77 40.83 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.244 179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.84 -77.46 0.21 Allowed Glycine 0 C--N 1.337 0.621 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -174.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -83.56 -168.02 1.94 Allowed 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 171.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.04 58.54 13.14 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 118.239 -1.934 . . . . 0.0 108.78 -171.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -166.6 163.37 36.93 Favored Glycine 0 N--CA 1.431 -1.695 0 CA-C-N 114.613 -0.794 . . . . 0.0 111.301 -171.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.15 127.33 3.38 Favored Glycine 0 N--CA 1.43 -1.722 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' HG3' ' HD3' ' A' ' 62' ' ' PRO . 5.7 tp10 -165.71 162.19 18.57 Favored 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.081 -173.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.629 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 32.6 p90 -162.18 63.81 1.56 Allowed Pre-proline 0 C--N 1.307 -1.255 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.134 -178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.454 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 91.9 Cg_endo -93.72 3.11 3.15 Favored 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.822 2.348 . . . . 0.0 112.263 -175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -146.42 9.91 1.09 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.57 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 76.7 mt 71.73 107.31 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.568 0 CA-C-N 115.188 -0.914 . . . . 0.0 109.978 -177.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.629 ' HD3' ' HB2' ' A' ' 61' ' ' TRP . 73.8 Cg_endo -85.64 51.07 2.8 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 123.018 2.479 . . . . 0.0 112.491 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 14.8 m -79.9 -5.38 55.45 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.283 0.563 . . . . 0.0 110.8 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -88.91 -174.96 4.69 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.734 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.145 0 CA-C-O 118.717 -1.046 . . . . 0.0 111.329 177.943 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -83.67 69.63 10.18 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.069 0.461 . . . . 0.0 110.572 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -151.79 147.56 26.81 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.751 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.521 ' H ' HD23 ' A' ' 4' ' ' LEU . 1.3 pt? -80.3 -31.82 38.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.562 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -133.39 145.92 50.77 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -106.54 -24.45 12.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.781 0.8 . . . . 0.0 108.888 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.731 HG21 ' O ' ' A' ' 47' ' ' PRO . 4.8 t -123.91 153.8 40.64 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.704 177.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.6 m -73.67 -17.78 61.1 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.237 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.408 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 34.7 m -98.14 10.45 40.49 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.17 -35.0 72.77 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.483 0.659 . . . . 0.0 111.34 178.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.543 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -64.98 -9.03 18.44 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.318 -178.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.1 ptp -53.0 -19.32 2.56 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -112.27 28.02 9.13 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.018 -0.673 . . . . 0.0 110.927 -179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.43 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 32.9 t70 -105.13 13.53 30.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.499 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.48 177.27 23.29 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.703 -0.761 . . . . 0.0 111.868 -175.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.47 -34.39 66.85 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.15 -36.95 66.73 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -59.78 -36.73 90.88 Favored Glycine 0 N--CA 1.45 -0.373 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 176.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.89 -31.59 72.82 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 121.476 0.655 . . . . 0.0 109.334 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 20' ' ' LYS . 13.3 tppt? -73.32 -46.42 49.6 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.994 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.3 t -61.92 -44.25 98.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.98 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.466 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.78 -54.95 41.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.18 178.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.3 pt20 -61.92 -40.85 96.91 Favored 'General case' 0 C--O 1.22 -0.492 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.039 -178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.87 -48.22 79.94 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 120.904 0.383 . . . . 0.0 110.963 -178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.16 77.24 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.439 179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 32.1 t -73.42 -54.82 7.37 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.972 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG22 ' HD2' ' A' ' 31' ' ' LYS . 83.8 mt -54.74 -52.34 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.997 -178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.1 p -60.11 -46.2 90.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.245 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.9 t -61.44 -34.84 76.09 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.03 0.443 . . . . 0.0 110.456 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 35' ' ' CYS . 97.4 m -67.6 -46.26 73.08 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.538 ' HD2' HG22 ' A' ' 27' ' ' ILE . 5.0 mtpm? -58.32 -39.56 79.73 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.056 178.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -61.73 -30.19 70.61 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -98.32 18.31 16.72 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.131 0.491 . . . . 0.0 111.002 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.4 t30 71.08 49.08 0.35 Allowed 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.75 177.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 86.7 m -119.34 136.4 54.28 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.678 174.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -56.34 -41.47 87.48 Favored Glycine 0 C--N 1.321 -0.251 0 CA-C-N 116.115 -0.493 . . . . 0.0 112.733 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.3 t -158.75 -179.64 8.25 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.857 0.36 . . . . 0.0 111.098 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -150.36 150.87 22.96 Favored Glycine 0 N--CA 1.43 -1.719 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.733 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -149.68 152.02 34.66 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.0 m -85.4 127.34 34.34 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 120.994 0.426 . . . . 0.0 110.684 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -134.96 140.6 45.83 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.574 -178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 -91.13 122.42 33.75 Favored 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 121.318 0.58 . . . . 0.0 111.047 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -105.57 99.19 8.8 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.181 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.14 53.38 46.87 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.645 -178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.02 -20.88 5.25 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 121.352 -0.452 . . . . 0.0 113.774 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -90.9 111.21 46.92 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 117.023 0.412 . . . . 0.0 111.812 -175.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.731 ' O ' HG21 ' A' ' 7' ' ' THR . 30.2 Cg_endo -64.02 125.39 15.18 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.251 1.967 . . . . 0.0 110.486 178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 m -137.53 155.29 49.41 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.571 -0.452 . . . . 0.0 110.669 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.408 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 9.9 t -91.87 106.84 18.77 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 177.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.8 m -107.79 126.83 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 CA-C-O 121.369 0.604 . . . . 0.0 110.082 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.485 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 35.7 m -90.44 152.91 20.76 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.496 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 18.6 m -125.68 152.65 44.97 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.597 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? 62.03 51.2 3.74 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 121.198 0.523 . . . . 0.0 109.962 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 51' ' ' CYS . 71.1 m -99.21 159.83 14.7 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.822 -178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.91 124.03 22.84 Favored Glycine 0 N--CA 1.434 -1.486 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 173.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -151.1 154.03 36.18 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 117.253 0.526 . . . . 0.0 110.826 -174.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 168.47 -77.7 0.11 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 75.41 19.32 79.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.286 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 85.06 -146.28 21.91 Favored Glycine 0 N--CA 1.435 -1.4 0 C-N-CA 120.414 -0.898 . . . . 0.0 110.968 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -156.52 153.6 29.0 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.482 ' HB3' ' HA ' ' A' ' 64' ' ' LEU . 6.2 m-90 -136.81 86.92 20.63 Favored Pre-proline 0 C--N 1.3 -1.583 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.02 -178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.35 -59.62 0.17 Allowed 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.324 2.016 . . . . 0.0 111.991 -179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -91.26 6.59 44.6 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.174 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.482 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 82.3 mt 57.84 71.39 1.07 Allowed Pre-proline 0 N--CA 1.469 0.484 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.681 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.14 99.88 1.02 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.636 2.224 . . . . 0.0 111.475 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 68.5 m -154.99 157.21 37.32 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.76 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -84.18 -30.95 25.4 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.169 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.426 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.403 0 N-CA-C 111.857 -0.497 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -80.78 91.88 5.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.723 0.296 . . . . 0.0 110.862 -178.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -161.67 149.06 14.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.88 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -77.74 -27.01 50.34 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.148 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -125.66 149.46 48.42 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.71 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 22.8 p90 -102.94 -27.06 12.86 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -123.94 134.71 53.46 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.691 176.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -53.83 -22.89 10.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.412 ' SG ' ' HB2' ' A' ' 49' ' ' CYS . 48.3 m -98.0 10.88 39.28 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.19 -27.85 69.26 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.15 0.5 . . . . 0.0 111.155 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.31 -11.02 37.55 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.674 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.53 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.0 ptp -55.87 -18.96 10.07 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 179.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -109.75 24.29 13.24 Favored 'General case' 0 C--N 1.338 0.073 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.104 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.49 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 25.3 t70 -101.69 25.54 8.41 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.11 -179.56 38.02 Favored Glycine 0 N--CA 1.443 -0.894 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.418 -176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.87 68.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.699 0.285 . . . . 0.0 111.719 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -65.04 -45.7 84.32 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.49 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -57.32 -38.84 88.77 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.17 179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.76 -44.77 77.95 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.782 0.325 . . . . 0.0 110.974 178.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.416 ' O ' ' HG2' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -68.83 -39.08 80.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.798 178.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 17' ' ' LEU . 41.3 t -60.92 -48.87 87.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.19 0.519 . . . . 0.0 109.997 176.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.81 -52.19 64.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.703 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.597 ' O ' HG13 ' A' ' 27' ' ' ILE . 20.7 pt20 -61.36 -40.71 95.29 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 120.984 -0.286 . . . . 0.0 110.523 -178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.5 -48.73 78.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.533 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.18 -34.92 75.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.766 177.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 31.7 t -71.5 -53.12 14.93 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.075 -179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 23' ' ' GLN . 78.3 mt -55.73 -49.3 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.102 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.775 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.2 p -58.64 -49.69 76.6 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.099 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 t -59.96 -36.63 77.52 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.957 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 95.9 m -66.53 -47.61 72.35 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.727 179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 17.0 mttm -55.21 -41.95 72.7 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.862 177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -59.52 -35.88 75.02 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -93.88 24.93 3.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.97 0.414 . . . . 0.0 111.486 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 63.4 t30 70.03 28.25 4.15 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.947 175.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 79.5 m -103.16 140.31 37.52 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.873 177.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -60.84 -42.85 99.72 Favored Glycine 0 CA--C 1.504 -0.641 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.666 -178.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -156.91 -179.99 8.74 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.85 178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' HA2' ' HA ' ' A' ' 51' ' ' CYS . . . -149.85 153.27 25.01 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.474 -0.784 . . . . 0.0 112.084 -178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -149.15 148.26 29.43 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 80.7 m -84.73 125.76 32.82 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.138 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -129.7 136.99 50.35 Favored 'General case' 0 N--CA 1.427 -1.583 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.825 -177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.53 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.8 mtp180 -92.9 119.72 32.5 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-O 121.182 0.515 . . . . 0.0 110.62 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 93.5 mtt180 -124.1 115.58 21.38 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.872 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 60.06 42.92 98.65 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.373 -176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.91 -4.03 32.98 Favored Glycine 0 N--CA 1.462 0.373 0 C-N-CA 121.483 -0.389 . . . . 0.0 113.178 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 -97.26 112.04 59.84 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -178.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 109.3 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.264 1.976 . . . . 0.0 110.457 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.9 m -123.32 154.87 38.31 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.327 -174.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 11.6 t -92.57 112.66 24.69 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 176.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 m -113.96 126.74 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.353 0 CA-C-O 121.392 0.615 . . . . 0.0 110.209 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 58.2 m -88.3 152.45 21.93 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.598 -176.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.1 m -130.94 152.98 49.67 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.18 178.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 59.07 52.27 6.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.574 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 70.8 m -86.84 -169.82 2.8 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.282 -178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -66.03 83.35 0.09 OUTLIER Glycine 0 C--N 1.343 0.918 0 C-N-CA 121.438 -0.41 . . . . 0.0 112.649 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -86.71 25.79 1.21 Allowed 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 122.894 0.478 . . . . 0.0 111.652 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.73 -98.06 0.51 Allowed Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.392 -0.908 . . . . 0.0 111.481 179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.92 36.49 0.53 Allowed Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.679 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.68 -143.72 16.68 Favored Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.408 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -91.68 -36.16 13.77 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.506 ' HB2' HD23 ' A' ' 64' ' ' LEU . 90.0 m95 -145.13 132.34 10.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -53.65 -39.42 83.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.246 2.631 . . . . 0.0 113.515 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -142.58 13.6 1.94 Allowed 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.025 0.441 . . . . 0.0 111.107 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.506 HD23 ' HB2' ' A' ' 61' ' ' TRP . 61.1 mt 60.29 84.53 0.2 Allowed Pre-proline 0 N--CA 1.478 0.943 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.357 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 61' ' ' TRP . 98.3 Cg_endo -87.24 -1.47 7.78 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.472 2.115 . . . . 0.0 111.931 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 45.8 t -79.87 141.8 35.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.001 -179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' NE ' ' A' ' 67' ' ' ARG . 2.4 mmp_? -87.51 -17.54 31.85 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.796 0.331 . . . . 0.0 111.168 179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.486 0 CA-C-O 118.809 -0.995 . . . . 0.0 111.756 -179.525 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.286 0 N-CA-C 112.261 -0.336 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -123.97 23.21 8.63 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.454 0.645 . . . . 0.0 109.992 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -101.36 108.38 19.98 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.664 -179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.633 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -81.34 -37.66 27.94 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.916 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -105.67 141.25 37.44 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -106.34 -29.4 9.78 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.023 0.44 . . . . 0.0 110.607 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.1 p -124.12 145.89 48.99 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.007 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -28.08 65.93 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.728 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 36.2 m -95.23 10.37 36.28 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.918 0.71 . . . . 0.0 112.918 -177.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.75 -28.54 67.47 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.175 0.512 . . . . 0.0 110.645 177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -12.31 32.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.142 -0.481 . . . . 0.0 112.118 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.462 ' SD ' ' HG3' ' A' ' 42' ' ' ARG . 11.4 ptp -56.08 -19.75 14.3 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -109.09 26.87 10.12 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.285 0.564 . . . . 0.0 109.935 -179.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.491 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 13.5 t70 -111.02 16.8 20.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.604 0.716 . . . . 0.0 109.361 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 100.02 179.59 30.23 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.27 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.37 -34.31 68.7 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.3 OUTLIER -73.0 -38.57 66.56 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.485 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.26 -39.46 96.05 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.637 176.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.76 80.66 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.181 0.515 . . . . 0.0 109.851 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.23 -44.05 80.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.207 179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 17' ' ' LEU . 46.5 t -63.6 -45.92 96.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.071 0.462 . . . . 0.0 110.083 177.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' HB1' ' SG ' ' A' ' 40' ' ' CYS . . . -58.32 -53.09 62.17 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.498 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.526 ' O ' HG13 ' A' ' 27' ' ' ILE . 16.7 pt20 -62.24 -40.5 96.37 Favored 'General case' 0 C--O 1.223 -0.337 0 C-N-CA 121.065 -0.254 . . . . 0.0 110.95 -178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.81 -48.3 79.7 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 121.007 0.432 . . . . 0.0 110.392 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -63.57 -34.14 77.16 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.601 178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.401 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 33.9 t -72.12 -54.07 10.85 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.224 -177.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.586 ' O ' ' HG3' ' A' ' 31' ' ' LYS . 69.1 mt -55.83 -52.08 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.682 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.0 p -58.3 -45.63 87.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.747 -179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.6 m -63.4 -33.33 75.31 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 120.856 0.36 . . . . 0.0 110.937 179.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 84.8 m -66.65 -46.31 76.16 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.025 0.441 . . . . 0.0 110.258 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 27' ' ' ILE . 4.0 mtpm? -59.65 -38.04 80.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.078 0.466 . . . . 0.0 109.808 178.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -58.66 -37.69 76.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.32 178.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.431 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 11.3 pt20 -95.03 18.05 12.82 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-O 120.811 0.338 . . . . 0.0 111.395 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 66.1 t30 70.09 49.36 0.48 Allowed 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.179 177.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 80.9 m -121.58 135.3 55.01 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.351 176.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -62.2 -38.95 97.01 Favored Glycine 0 C--O 1.229 -0.179 0 CA-C-N 115.45 -0.796 . . . . 0.0 113.677 -176.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.1 t -152.55 164.29 37.91 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.497 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.511 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -144.58 146.52 17.04 Favored Glycine 0 N--CA 1.425 -2.072 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.531 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 29.7 p-80 -149.29 152.17 35.44 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.437 ' SG ' ' HB1' ' A' ' 22' ' ' ALA . 64.5 m -83.67 127.81 34.05 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.029 0.442 . . . . 0.0 110.89 -177.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.2 139.52 48.37 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HG3' ' SD ' ' A' ' 12' ' ' MET . 13.4 mtp180 -89.06 114.95 26.23 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 121.196 0.522 . . . . 0.0 110.549 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -105.64 104.16 13.82 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.299 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 58.95 52.63 52.24 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.018 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.88 -19.88 4.02 Favored Glycine 0 CA--C 1.518 0.237 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.62 -178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -91.29 113.53 58.72 Favored Pre-proline 0 C--N 1.314 -0.937 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -176.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.02 113.84 2.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.508 2.138 . . . . 0.0 110.925 177.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 m -127.09 154.88 44.14 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-O 120.827 0.346 . . . . 0.0 110.843 -176.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 19.0 t -92.48 109.61 21.01 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.7 m -106.83 128.86 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.76 0 CA-C-O 121.195 0.521 . . . . 0.0 110.21 -179.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 37.9 m -98.45 152.58 19.36 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.297 0.57 . . . . 0.0 111.859 -177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.8 m -127.24 153.58 45.94 Favored 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.384 -0.825 . . . . 0.0 109.37 177.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.581 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 2.8 mmp_? 58.34 55.87 4.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.212 0.529 . . . . 0.0 111.795 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 83.3 m -90.05 154.48 19.77 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 177.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -91.01 51.54 3.18 Favored Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.1 -1.047 . . . . 0.0 111.917 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -72.66 -43.71 62.8 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 121.244 -0.182 . . . . 0.0 110.963 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 101.29 100.44 2.44 Favored Glycine 0 N--CA 1.434 -1.464 0 C-N-CA 119.867 -1.159 . . . . 0.0 111.87 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.6 -17.74 1.19 Allowed Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 71.93 67.6 1.81 Allowed Glycine 0 N--CA 1.433 -1.524 0 C-N-CA 121.133 -0.556 . . . . 0.0 112.446 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -82.9 131.75 35.18 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 175.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -136.89 86.15 21.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 CA-C-O 120.616 0.246 . . . . 0.0 110.679 -178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.59 88.84 1.38 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.639 2.226 . . . . 0.0 111.04 177.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.15 35.59 18.47 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.816 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 88.1 mt 68.46 105.57 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.217 -0.902 . . . . 0.0 110.133 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.41 34.44 0.43 Allowed 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 123.224 2.616 . . . . 0.0 113.682 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 48.0 m -149.63 147.58 28.28 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.836 0.35 . . . . 0.0 110.999 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -147.82 169.03 20.66 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.39 176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.418 -1.212 . . . . 0.0 111.632 -179.776 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.339 0 N-CA-C 112.033 -0.427 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.8 p -80.19 96.55 6.6 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.369 0.604 . . . . 0.0 111.172 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.03 149.49 24.75 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.483 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.56 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -79.04 -27.39 43.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.94 0.4 . . . . 0.0 110.333 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.43 147.82 33.83 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.9 p90 -102.31 -25.56 13.62 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.027 0.441 . . . . 0.0 111.061 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 p -123.7 152.08 42.47 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.216 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.7 p -63.06 -26.37 68.81 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.624 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 45.7 m -100.15 12.27 37.37 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.15 -29.81 70.01 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.053 0.454 . . . . 0.0 111.222 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.526 ' HG2' ' HB2' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -66.42 -8.89 28.82 Favored 'General case' 0 C--O 1.222 -0.378 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 179.288 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.492 ' SD ' ' HB3' ' A' ' 47' ' ' PRO . 10.5 ptp -57.65 -10.9 1.75 Allowed 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 120.933 0.397 . . . . 0.0 110.39 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -111.71 19.1 18.37 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 122.897 0.479 . . . . 0.0 110.172 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.492 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 11.4 t70 -110.7 14.64 22.26 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.08 0.467 . . . . 0.0 110.954 -175.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.52 177.37 26.1 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.259 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.36 -39.06 56.29 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.043 0.537 . . . . 0.0 112.139 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.528 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.07 -40.52 71.57 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.42 -45.3 96.47 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.785 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.17 -35.74 72.02 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.974 0.416 . . . . 0.0 111.134 178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.62 -40.69 72.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.603 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 17' ' ' LEU . 57.7 t -64.6 -43.5 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.675 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.526 ' HB2' ' HG2' ' A' ' 11' ' ' ARG . . . -57.83 -55.73 31.12 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.316 -179.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.546 ' O ' HG13 ' A' ' 27' ' ' ILE . 18.6 pt20 -60.74 -41.45 95.38 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.13 -47.62 79.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.827 0.346 . . . . 0.0 110.773 -179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.5 -36.24 81.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 44.9 t -70.45 -51.37 29.79 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.641 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.8 mt -55.55 -48.66 77.12 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.178 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.7 m -59.68 -47.7 84.59 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.2 t -59.23 -37.7 78.17 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.053 0.454 . . . . 0.0 110.483 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.548 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 85.9 m -66.66 -46.25 76.3 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.424 178.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp -59.08 -39.24 81.55 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.431 178.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -57.49 -35.8 70.69 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.647 0.26 . . . . 0.0 111.504 176.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' SG ' ' A' ' 35' ' ' CYS . 10.6 pt20 -96.57 15.14 22.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.785 0.326 . . . . 0.0 111.229 -178.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.7 t30 68.67 50.12 0.68 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.683 0.754 . . . . 0.0 111.555 177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 91.2 m -118.13 132.91 56.31 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.634 175.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.53 -43.98 93.95 Favored Glycine 0 CA--C 1.51 -0.247 0 CA-C-N 115.627 -0.715 . . . . 0.0 114.097 -175.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 t -155.07 141.65 18.84 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.481 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.548 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -116.8 152.39 17.88 Favored Glycine 0 N--CA 1.436 -1.351 0 CA-C-N 115.595 -0.729 . . . . 0.0 112.027 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -149.58 150.46 32.27 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.449 ' HB3' ' CE ' ' A' ' 12' ' ' MET . 71.9 m -85.45 126.3 33.7 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.362 -178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -135.86 144.51 45.65 Favored 'General case' 0 N--CA 1.436 -1.128 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.412 -179.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -88.76 114.92 25.89 Favored 'General case' 0 CA--C 1.495 -1.146 0 CA-C-O 121.574 0.702 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.0 mmt180 -106.83 103.83 13.35 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.26 -179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.3 51.54 57.42 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -177.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.92 -2.8 7.62 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.253 -0.499 . . . . 0.0 113.82 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 4.0 mmp_? -101.25 112.85 65.63 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 117.189 0.494 . . . . 0.0 112.189 -177.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HB3' ' SD ' ' A' ' 12' ' ' MET . 31.0 Cg_endo -64.29 104.28 0.5 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.526 2.151 . . . . 0.0 111.185 178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.5 m -120.59 155.16 34.3 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.522 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.403 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 8.5 t -90.79 112.69 24.59 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 m -113.05 126.8 70.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.955 0 CA-C-O 121.366 0.603 . . . . 0.0 110.678 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 28.8 m -94.76 155.38 16.85 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.948 -177.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 31.2 m -134.74 156.69 48.39 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.393 177.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 53' ' ' ARG . 22.1 mmt180 59.0 54.94 4.72 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-O 121.389 0.614 . . . . 0.0 111.323 -177.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.527 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 81.0 m -91.48 149.5 21.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.513 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.92 -96.37 0.59 Allowed Glycine 0 N--CA 1.439 -1.154 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.326 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -132.41 -53.58 0.95 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.59 -113.29 0.45 Allowed Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.027 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -112.75 -50.94 0.54 Allowed Glycine 0 N--CA 1.444 -0.787 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.602 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 59.59 74.77 0.32 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 121.581 -0.342 . . . . 0.0 112.815 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.74 174.04 15.64 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.73 0.3 . . . . 0.0 111.262 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -144.99 87.22 7.33 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-O 121.471 0.653 . . . . 0.0 111.209 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.2 -24.05 8.39 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.804 2.336 . . . . 0.0 112.666 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -83.85 -21.72 31.94 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.852 0.358 . . . . 0.0 110.409 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 65.3 mt 64.66 89.04 0.11 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.158 178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -78.64 171.53 16.57 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.158 1.906 . . . . 0.0 110.747 177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 24.9 t -76.66 96.55 4.21 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.37 0.605 . . . . 0.0 109.483 178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -83.06 129.03 34.99 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.544 -177.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.093 0 CA-C-O 118.206 -1.33 . . . . 0.0 110.574 177.527 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.098 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.7 m -90.59 19.13 5.58 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.455 0.645 . . . . 0.0 111.272 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -119.26 165.9 13.67 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.322 -0.854 . . . . 0.0 108.775 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.63 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.5 pt? -82.62 -47.91 11.54 Favored 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 120.462 -0.495 . . . . 0.0 109.845 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.447 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 1.6 m-20 -94.91 132.04 40.18 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.052 177.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CD2' HG23 ' A' ' 7' ' ' THR . 18.6 p90 -102.97 -27.79 12.41 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 177.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 HG23 ' CD2' ' A' ' 6' ' ' PHE . 7.3 p -122.25 154.26 37.77 Favored 'General case' 0 N--CA 1.431 -1.392 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.805 175.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.5 m -73.91 -17.74 60.99 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.113 0.482 . . . . 0.0 111.598 -178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 26' ' ' CYS . 55.7 m -98.79 12.38 35.8 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -175.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.6 -28.27 65.44 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.525 0.679 . . . . 0.0 110.296 177.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -62.64 -13.74 35.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.911 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.4 ptp -56.64 -17.36 8.48 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -109.65 29.37 7.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.035 0.445 . . . . 0.0 110.503 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.578 ' HB3' ' HA3' ' A' ' 18' ' ' GLY . 36.9 t70 -114.96 14.08 17.13 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-O 121.595 0.712 . . . . 0.0 110.26 -178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.28 -176.2 30.13 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.355 -0.926 . . . . 0.0 112.889 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.26 -35.24 64.78 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.509 ' O ' HG23 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -73.56 -41.69 62.61 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.578 ' HA3' ' HB3' ' A' ' 14' ' ' ASP . . . -60.37 -43.99 98.06 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.055 178.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -39.18 73.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.129 0.49 . . . . 0.0 110.416 178.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -43.21 82.66 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.412 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 17' ' ' LEU . 59.4 t -63.33 -45.86 97.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.026 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.61 -53.09 62.07 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.286 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.509 ' O ' HG13 ' A' ' 27' ' ' ILE . 17.5 pt20 -62.0 -42.04 98.71 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.725 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.18 -47.97 80.36 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 120.834 0.349 . . . . 0.0 110.831 -179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -62.88 -36.2 82.53 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.304 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 9' ' ' CYS . 52.5 t -67.72 -53.84 24.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.937 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 23' ' ' GLN . 93.2 mt -55.59 -46.05 79.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.669 -178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.512 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 14.6 m -61.21 -45.61 93.85 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.134 179.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.0 m -60.79 -35.63 76.96 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.118 0.485 . . . . 0.0 110.643 178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.491 ' SG ' ' HA3' ' A' ' 38' ' ' GLY . 89.5 m -65.86 -47.63 74.26 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.742 177.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.512 ' HD2' ' HA ' ' A' ' 28' ' ' SER . 22.2 mttm -57.55 -36.54 71.77 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.139 178.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -59.71 -33.39 71.56 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 120.715 0.293 . . . . 0.0 111.674 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -97.25 17.17 17.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.179 0.514 . . . . 0.0 110.322 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 71.42 37.63 1.13 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.892 176.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 54' ' ' CYS . 86.1 m -113.74 130.81 56.38 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 121.248 0.546 . . . . 0.0 110.727 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -57.71 -46.71 91.91 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 115.0 -1.0 . . . . 0.0 114.688 -173.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.7 t -150.42 143.92 25.1 Favored 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 119.471 -0.892 . . . . 0.0 111.309 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' HA3' ' SG ' ' A' ' 30' ' ' CYS . . . -118.92 160.55 14.04 Favored Glycine 0 N--CA 1.433 -1.502 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.179 177.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -146.63 146.22 30.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 64.9 m -83.14 125.77 31.88 Favored 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.87 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -135.65 141.02 44.96 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.985 -178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -89.99 125.15 35.28 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.301 0.572 . . . . 0.0 110.684 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -131.09 121.64 25.31 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.055 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.05 96.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.235 -174.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.36 -7.42 6.32 Favored Glycine 0 C--N 1.344 0.989 0 C-N-CA 121.556 -0.354 . . . . 0.0 113.118 -177.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -93.48 115.28 64.83 Favored Pre-proline 0 C--N 1.308 -1.239 0 CA-C-O 120.592 0.234 . . . . 0.0 111.246 -176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.93 100.41 0.51 Allowed 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.356 2.038 . . . . 0.0 110.695 176.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 m -114.2 156.31 24.52 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.351 -173.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 11.2 t -91.17 117.85 29.96 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 176.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 126.02 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 121.388 0.613 . . . . 0.0 110.727 179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' HA ' ' HA2' ' A' ' 38' ' ' GLY . 19.3 m -91.28 154.62 19.12 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.0 m -139.28 160.2 40.38 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.847 -1.07 . . . . 0.0 109.705 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 3.3 mmp_? 57.78 64.98 1.41 Allowed 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.09 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' CYS . . . . . 0.712 ' HA ' ' HA ' ' A' ' 35' ' ' CYS . 66.2 m -87.2 145.06 26.55 Favored 'General case' 0 N--CA 1.411 -2.392 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.81 -82.63 0.27 Allowed Glycine 0 N--CA 1.423 -2.202 0 C-N-CA 120.538 -0.839 . . . . 0.0 113.741 -172.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -163.24 175.86 10.52 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 121.442 0.639 . . . . 0.0 112.272 -173.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.91 145.62 12.38 Favored Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 174.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 89.04 61.77 1.4 Allowed Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 119.802 -1.19 . . . . 0.0 111.501 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.74 42.3 1.39 Allowed Glycine 0 CA--C 1.508 -0.399 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -149.0 146.54 27.83 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.4 m-90 -146.02 78.1 11.66 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -79.41 87.79 1.51 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 122.149 1.899 . . . . 0.0 111.477 178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.3 t30 57.01 46.14 19.87 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.552 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.9 pp 46.11 103.71 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.344 1.057 . . . . 0.0 113.223 -175.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.82 158.31 55.92 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.194 1.929 . . . . 0.0 112.201 -177.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.5 m -81.49 -1.59 46.56 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.38 0.609 . . . . 0.0 110.408 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -85.84 113.62 22.13 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.752 178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.446 0 CA-C-O 118.331 -1.26 . . . . 0.0 111.695 -179.383 . . . . . . . . 0 0 . 1 stop_ save_